| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 5.98e-06 | 4 | 230 | 3 | GO:0005219 | |
| GeneOntologyMolecularFunction | calmodulin binding | DAPK2 RYR1 RYR2 RYR3 STRN SCN3A STRN3 MYLK2 MYO1F ATP2B2 ATP2B4 PCNT | 1.54e-05 | 230 | 230 | 12 | GO:0005516 |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 2.94e-05 | 6 | 230 | 3 | GO:0048763 | |
| GeneOntologyMolecularFunction | armadillo repeat domain binding | 1.20e-04 | 9 | 230 | 3 | GO:0070016 | |
| GeneOntologyMolecularFunction | protein phosphorylated amino acid binding | 1.43e-04 | 69 | 230 | 6 | GO:0045309 | |
| GeneOntologyMolecularFunction | P-type calcium transporter activity | 2.32e-04 | 11 | 230 | 3 | GO:0005388 | |
| GeneOntologyMolecularFunction | phosphoserine residue binding | 3.07e-04 | 12 | 230 | 3 | GO:0050815 | |
| GeneOntologyMolecularFunction | calcium ion binding | CLGN NCL PKDREJ RYR1 RYR2 RYR3 EHD4 S100A11 OTOF CCDC47 PCDH15 HSPA5 CALU CAPN1 EFHD2 PCDHA1 DNAH7 SYT15 ATP2A2 ATP2B2 | 4.40e-04 | 749 | 230 | 20 | GO:0005509 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF18A MCM6 ATP8A1 CHD6 HSPA5 DNAH3 CHD8 DNAH7 MLH3 FBH1 CHD5 ATP2A2 ATP2B2 ATP2B4 | 6.28e-04 | 441 | 230 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | ATPase-coupled monoatomic cation transmembrane transporter activity | 7.36e-04 | 62 | 230 | 5 | GO:0019829 | |
| GeneOntologyMolecularFunction | P-type transmembrane transporter activity | 7.56e-04 | 36 | 230 | 4 | GO:0140358 | |
| GeneOntologyMolecularFunction | P-type ion transporter activity | 7.56e-04 | 36 | 230 | 4 | GO:0015662 | |
| GeneOntologyMolecularFunction | myosin light chain kinase activity | 7.81e-04 | 4 | 230 | 2 | GO:0004687 | |
| GeneOntologyMolecularFunction | DNA topoisomerase binding | 7.81e-04 | 4 | 230 | 2 | GO:0044547 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF18A MCM6 ATP8A1 CHD6 HSPA5 SLC27A2 DNAH3 CHD8 DNAH7 MLH3 FBH1 CHD5 ATP6V0A4 MYO1F ATP2A2 ATP2B2 ATP2B4 | 7.96e-04 | 614 | 230 | 17 | GO:0140657 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 9.58e-04 | 262 | 230 | 10 | GO:0140097 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.08e-03 | 18 | 230 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | protein domain specific binding | WIPF3 TFDP3 DAPK3 NCL STRN PTPN6 TACC1 HSPA5 MPP7 STRN3 CHD8 XPO1 PPARG CREBBP YWHAE THRA ELMO2 ATP2B2 ICA1L ATP2B4 SON | 1.24e-03 | 875 | 230 | 21 | GO:0019904 |
| GeneOntologyMolecularFunction | small GTPase binding | KNTC1 MYCBP2 DAPK3 RABGAP1 DIAPH2 STRN3 XPO4 XPO1 VPS9D1 RAB3IP DAAM1 | 1.30e-03 | 321 | 230 | 11 | GO:0031267 |
| GeneOntologyBiologicalProcess | sexual reproduction | KIF18A SYCP2L KDM5B PLB1 CLGN USP9X STRA8 SPEF2 MEIKIN WIPF3 MEIOB MCM6 CNBD2 USP9Y PKDREJ S100A11 SBF1 NCAPD2 DIAPH2 AGFG1 MERTK ZMYND15 IFT27 SYNE1 MEI1 MST1R MLH3 CHD5 FBXO43 PABPC1L SSH2 CFAP44 ICA1L ATP2B4 | 7.34e-06 | 1312 | 237 | 34 | GO:0019953 |
| GeneOntologyBiologicalProcess | cell cycle process | KNTC1 KIF18A SYCP2L USP9X STRA8 MEIKIN STK38 MEIOB TFDP3 DAPK3 MCM6 DTX3L FOXN3 KIAA0753 PTPN6 PIN1 NCAPD2 MMS19 TACC1 OFD1 GTSE1 BAZ1B CEP192 MAU2 XPO1 MEI1 CREBBP LIG1 MLH3 PAXIP1 FBXO43 EXOC1 ATP2B4 PCM1 SON PCNT | 8.61e-06 | 1441 | 237 | 36 | GO:0022402 |
| GeneOntologyBiologicalProcess | male gamete generation | KIF18A CLGN STRA8 SPEF2 MEIKIN WIPF3 MEIOB CNBD2 USP9Y S100A11 SBF1 AGFG1 MERTK ZMYND15 IFT27 SYNE1 MEI1 MLH3 CHD5 SSH2 CFAP44 ICA1L ATP2B4 | 2.52e-05 | 762 | 237 | 23 | GO:0048232 |
| GeneOntologyBiologicalProcess | vesicle cargo loading | 5.41e-05 | 36 | 237 | 5 | GO:0035459 | |
| GeneOntologyBiologicalProcess | cilium assembly | USP9X SPEF2 RABGAP1 KIAA0753 EHD4 CEP350 PCDH15 IFT27 OFD1 SYNE1 DNAH7 IFT52 RAB3IP CFAP44 PCM1 PCNT | 5.96e-05 | 444 | 237 | 16 | GO:0060271 |
| GeneOntologyBiologicalProcess | gamete generation | KIF18A CLGN USP9X STRA8 SPEF2 MEIKIN WIPF3 MEIOB CNBD2 USP9Y S100A11 SBF1 DIAPH2 AGFG1 MERTK ZMYND15 IFT27 SYNE1 MEI1 MLH3 CHD5 PABPC1L SSH2 CFAP44 ICA1L ATP2B4 | 6.74e-05 | 982 | 237 | 26 | GO:0007276 |
| GeneOntologyBiologicalProcess | response to caffeine | 8.72e-05 | 21 | 237 | 4 | GO:0031000 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | EPHB2 USP9X SPEF2 RABGAP1 ITGB4 KIAA0753 EHD4 CEP350 PCDH15 NCK2 IFT27 OFD1 SYNE1 CARMIL1 DNAH7 IFT52 RAB3IP CFAP44 PCM1 PCNT | 1.00e-04 | 670 | 237 | 20 | GO:0120031 |
| GeneOntologyBiologicalProcess | organelle fission | KNTC1 KIF18A SYCP2L STRA8 MEIKIN MEIOB DAPK3 PIN1 NCAPD2 PEX19 OFD1 BAZ1B CEP192 PPARG MEI1 MLH3 VPS35 FBXO43 | 1.15e-04 | 571 | 237 | 18 | GO:0048285 |
| GeneOntologyBiologicalProcess | reproductive senescence | 1.31e-04 | 2 | 237 | 2 | GO:1990636 | |
| GeneOntologyBiologicalProcess | cilium organization | USP9X SPEF2 RABGAP1 KIAA0753 EHD4 CEP350 PCDH15 IFT27 OFD1 SYNE1 DNAH7 IFT52 RAB3IP CFAP44 PCM1 PCNT | 1.34e-04 | 476 | 237 | 16 | GO:0044782 |
| GeneOntologyBiologicalProcess | cell projection assembly | EPHB2 USP9X SPEF2 RABGAP1 ITGB4 KIAA0753 EHD4 CEP350 PCDH15 NCK2 IFT27 OFD1 SYNE1 CARMIL1 DNAH7 IFT52 RAB3IP CFAP44 PCM1 PCNT | 1.35e-04 | 685 | 237 | 20 | GO:0030031 |
| GeneOntologyBiologicalProcess | actin filament-based process | PDPK1 WIPF3 DAPK3 RYR2 NF1 MYLK3 SCN3A SCN9A PCDH15 FSCN2 DIAPH2 IQSEC1 PLEKHH2 NCK2 KRT19 CARMIL1 CAPN1 MYLK2 ELMO2 MYO1F SSH2 DAAM1 ATP2A2 PALLD | 1.43e-04 | 912 | 237 | 24 | GO:0030029 |
| GeneOntologyBiologicalProcess | response to transforming growth factor beta | USP9X PDPK1 USP9Y ITGB6 RYR1 PIN1 TAB1 HSPA5 MXRA5 PPARG CREBBP POSTN ZFHX3 | 1.80e-04 | 343 | 237 | 13 | GO:0071559 |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 7.08e-06 | 42 | 235 | 6 | GO:0070971 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 1.62e-04 | 46 | 235 | 5 | GO:0005790 | |
| Domain | ARM-like | USP9X USP9Y NF1 ANKAR NCAPD2 CAB39L MMS19 HECTD1 XPO4 NBEA HEATR1 XPO1 MEI1 PPP4R3B RIF1 ELMO2 DAAM1 ARMH4 | 7.15e-09 | 270 | 230 | 18 | IPR011989 |
| Domain | ARM-type_fold | USP9X USP9Y RYR3 NF1 ANKAR NCAPD2 DIAPH2 CAB39L MMS19 HECTD1 XPO4 NBEA HEATR1 XPO1 MEI1 PPP4R3B RIF1 ELMO2 VPS35 DAAM1 | 8.21e-09 | 339 | 230 | 20 | IPR016024 |
| Domain | RyR | 1.84e-06 | 3 | 230 | 3 | PF02026 | |
| Domain | RR_TM4-6 | 1.84e-06 | 3 | 230 | 3 | PF06459 | |
| Domain | Ryan_recept | 1.84e-06 | 3 | 230 | 3 | IPR013333 | |
| Domain | Ryanodine_rcpt | 1.84e-06 | 3 | 230 | 3 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 1.84e-06 | 3 | 230 | 3 | IPR009460 | |
| Domain | - | USP9X NF1 ANKAR NCAPD2 CAB39L MMS19 HECTD1 XPO4 HEATR1 XPO1 RIF1 ELMO2 DAAM1 | 3.94e-06 | 222 | 230 | 13 | 1.25.10.10 |
| Domain | Ryanodine_recept-rel | 3.59e-05 | 6 | 230 | 3 | IPR015925 | |
| Domain | - | 3.59e-05 | 6 | 230 | 3 | 1.25.10.30 | |
| Domain | RIH_assoc-dom | 3.59e-05 | 6 | 230 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 3.59e-05 | 6 | 230 | 3 | PF08709 | |
| Domain | RIH_assoc | 3.59e-05 | 6 | 230 | 3 | PF08454 | |
| Domain | RIH_dom | 3.59e-05 | 6 | 230 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 3.59e-05 | 6 | 230 | 3 | IPR014821 | |
| Domain | RYDR_ITPR | 3.59e-05 | 6 | 230 | 3 | PF01365 | |
| Domain | CRM1_C | 1.51e-04 | 2 | 230 | 2 | PF08767 | |
| Domain | CRM1_C_dom | 1.51e-04 | 2 | 230 | 2 | IPR014877 | |
| Domain | RRM_dom_euk | 1.65e-04 | 23 | 230 | 4 | IPR003954 | |
| Domain | RRM_1 | 1.65e-04 | 23 | 230 | 4 | SM00361 | |
| Domain | MIR | 2.08e-04 | 10 | 230 | 3 | PF02815 | |
| Domain | MIR_motif | 2.08e-04 | 10 | 230 | 3 | IPR016093 | |
| Domain | MIR | 2.08e-04 | 10 | 230 | 3 | PS50919 | |
| Domain | MIR | 2.08e-04 | 10 | 230 | 3 | SM00472 | |
| Domain | - | 4.49e-04 | 3 | 230 | 2 | 1.10.1370.10 | |
| Domain | Striatin | 4.49e-04 | 3 | 230 | 2 | PF08232 | |
| Domain | GPCR_2_VIP_rcpt_1 | 4.49e-04 | 3 | 230 | 2 | IPR001771 | |
| Domain | Neurolysin/TOP_N | 4.49e-04 | 3 | 230 | 2 | IPR024080 | |
| Domain | Neurolysin/TOP_dom2 | 4.49e-04 | 3 | 230 | 2 | IPR024077 | |
| Domain | - | 4.49e-04 | 3 | 230 | 2 | 1.20.1050.40 | |
| Domain | Striatin_N | 4.49e-04 | 3 | 230 | 2 | IPR013258 | |
| Domain | Pept_M3A_M3B | 4.49e-04 | 3 | 230 | 2 | IPR001567 | |
| Domain | Peptidase_M3 | 4.49e-04 | 3 | 230 | 2 | PF01432 | |
| Domain | DAPK1 | 4.49e-04 | 3 | 230 | 2 | IPR020676 | |
| Domain | EF-hand_8 | 7.77e-04 | 34 | 230 | 4 | PF13833 | |
| Domain | ATPase_P-typ_cyto_domN | 8.69e-04 | 35 | 230 | 4 | IPR023299 | |
| Domain | ATP_Ca_trans_C | 8.91e-04 | 4 | 230 | 2 | IPR022141 | |
| Domain | ATP_Ca_trans_C | 8.91e-04 | 4 | 230 | 2 | PF12424 | |
| Domain | P-type_ATPase_IIB | 8.91e-04 | 4 | 230 | 2 | IPR006408 | |
| Domain | EF-hand-dom_pair | SPEF2 RYR1 RYR2 RYR3 EHD4 S100A11 SCN3A SCN9A CALU CAPN1 EFHD2 | 8.97e-04 | 287 | 230 | 11 | IPR011992 |
| Domain | ATPase_P-typ_TM_dom | 9.17e-04 | 16 | 230 | 3 | IPR023298 | |
| Domain | - | 9.17e-04 | 16 | 230 | 3 | 1.20.1110.10 | |
| Domain | ATPase_P-typ_P_site | 9.69e-04 | 36 | 230 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 9.69e-04 | 36 | 230 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 9.69e-04 | 36 | 230 | 4 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.08e-03 | 37 | 230 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.08e-03 | 37 | 230 | 4 | PF00122 | |
| Domain | Cation_ATPase_C | 1.10e-03 | 17 | 230 | 3 | PF00689 | |
| Domain | ATPase_P-typ_cation-transptr_C | 1.10e-03 | 17 | 230 | 3 | IPR006068 | |
| Domain | Cation_ATPase_N | 1.31e-03 | 18 | 230 | 3 | PF00690 | |
| Domain | Cation_ATPase_N | 1.31e-03 | 18 | 230 | 3 | SM00831 | |
| Domain | PolyA | 1.47e-03 | 5 | 230 | 2 | SM00517 | |
| Domain | PABP | 1.47e-03 | 5 | 230 | 2 | PF00658 | |
| Domain | PABC | 1.47e-03 | 5 | 230 | 2 | PS51309 | |
| Domain | - | 1.47e-03 | 5 | 230 | 2 | 1.10.1900.10 | |
| Domain | PABP_1234 | 1.47e-03 | 5 | 230 | 2 | IPR006515 | |
| Domain | PABP_HYD | 1.47e-03 | 5 | 230 | 2 | IPR002004 | |
| Domain | ATPase_P-typ_cation-transptr_N | 1.54e-03 | 19 | 230 | 3 | IPR004014 | |
| Domain | ConA-like_dom | 1.62e-03 | 219 | 230 | 9 | IPR013320 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 5.82e-05 | 54 | 178 | 6 | M27460 | |
| Pathway | REACTOME_ION_HOMEOSTASIS | 5.82e-05 | 54 | 178 | 6 | MM15202 | |
| Pubmed | KIF18A MYCBP2 RPN2 USP9X DAPK3 KIAA0753 EHD4 CEP350 PTPN3 PTPN6 HSPA12A PTPRD SBF1 PMPCA MTUS1 CCDC47 SEC16A PEX19 C1QBP USP12 TAB1 CPSF2 HSD17B4 HSPA5 MPP7 NCK2 CAD OFD1 CALU ZNF280C XPO4 NBEA CEP192 XPO1 STAM YWHAE MADD PDIA4 POSTN PPP4R3B RIF1 FANCI SSH2 CRYBG3 ATP2A2 ATP2B4 PCNT | 9.27e-25 | 1049 | 239 | 47 | 27880917 | |
| Pubmed | MYCBP2 RPN2 RPS2 USP9X PABPC4 MCM6 NCL TTF1 NF1 SBF1 NCAPD2 SEC16A HECTD1 CAD PUF60 CAPN1 BAZ1B CHD8 HEATR1 XPO1 ZCCHC3 PDIA4 RIF1 UTP25 PHF3 FANCI RBM6 MPHOSPH10 ATP2A2 PCM1 SON PCNT | 3.96e-18 | 653 | 239 | 32 | 22586326 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KDM5B MYCBP2 DAPK2 DAPK3 KIAA0753 CEP350 PTPN3 NF1 MYLK3 SBF1 MTUS1 SEC16A IQSEC1 AGFG1 TAB1 SIPA1L2 HECTD1 OFD1 KRT19 CALU CARMIL1 GTSE1 CEP192 DNAH7 YWHAE MADD MYLK2 SRRT ELMO2 PHF3 PLEKHM3 SSH2 CRYBG3 PALLD PCM1 | 3.17e-17 | 861 | 239 | 35 | 36931259 |
| Pubmed | RPS2 USP9X MCM6 NCL ITGB4 S100A11 NCAPD2 SEC16A STRN3 CAD CALU GTSE1 EFHD2 CHD8 STAM PPP4R3B SRRT LIG1 RIF1 PHF3 FANCI RBM6 TRIM47 PALLD PCM1 SON | 1.88e-15 | 503 | 239 | 26 | 16964243 | |
| Pubmed | KNTC1 RPN2 SPEF2 PABPC4 FAM114A2 NCL RYR2 EHD4 RPS6KC1 STRN RUNDC3A PMPCA SACS CCDC47 NCAPD2 SCN9A CHD6 CTAGE4 HSD17B4 SIPA1L2 HSPA5 STRN3 KRT19 SYNE1 RDH12 CTAGE6 HEATR1 SRBD1 MYLK2 PDIA4 CHD5 VPS35 CTAGE8 MTTP CTAGE15 PABPC1L ZNF84 MPHOSPH10 ATP2A2 ATP2B2 PCNT | 1.09e-14 | 1442 | 239 | 41 | 35575683 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MYCBP2 RPS2 USP9X PABPC4 MCM6 NCL EHD4 CEP350 NF1 SACS PIN1 SEC16A C1QBP CPSF2 HSD17B4 MGA HSPA5 CAD OFD1 PUF60 SYNE1 GTSE1 BAZ1B HEATR1 XPO1 YWHAE PDIA4 SRRT RIF1 ATP2A2 PCM1 SON PCNT | 1.94e-13 | 1024 | 239 | 33 | 24711643 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SETD1A MYCBP2 RPS2 USP9X MCM6 NCL RPS6KC1 NF1 SBF1 SEC16A C1QBP MMS19 HECTD1 CAD CHD8 PPP4R3B SRRT UTP25 PHF3 RBM6 MPHOSPH10 | 4.85e-12 | 440 | 239 | 21 | 34244565 |
| Pubmed | PABPC4 STK38 RTF1 STRN SEC16A TACC1 CPSF2 HSD17B4 STRN3 GTSE1 ZNF280C CHD8 HEATR1 SRBD1 YWHAE RSBN1 LIG1 RIF1 PHF3 MPHOSPH10 CRYBG3 | 1.81e-11 | 472 | 239 | 21 | 38943005 | |
| Pubmed | KDM5B USP9X NCL FOXN3 PEX19 MMS19 TAF5 ZFAT GTSE1 BAZ1B XPO4 CHD8 CREBBP YWHAE RIF1 THOP1 UTP25 EXOC1 | 2.48e-11 | 335 | 239 | 18 | 15741177 | |
| Pubmed | RPS2 USP9X PABPC4 MCM6 PMPCA CCDC47 TAB1 HSD17B4 HECTD1 HSPA5 IFT27 CAD APEH CHD8 XPO1 YWHAE PDIA4 SRRT LIG1 FANCI VPS35 PALLD | 2.59e-11 | 534 | 239 | 22 | 35032548 | |
| Pubmed | MYCBP2 RPN2 RPS2 USP9X NCL EHD4 CEP350 NF1 ATP8A1 CCDC47 NCAPD2 IQSEC1 CHST12 MMS19 CPSF2 HSPA5 CAD OFD1 CALU GTSE1 B3GALT6 HEATR1 XPO1 YWHAE FANCI CHD5 CD58 EXOC1 DAAM1 ATP2B4 PCM1 PCNT | 3.21e-11 | 1168 | 239 | 32 | 19946888 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SETD1A MYCBP2 RPS2 MCM6 NCL NPM3 EHD4 NF1 SBF1 CCDC47 PIN1 NCAPD2 SEC16A IQSEC1 MMS19 MGA HSPA5 CAD CAPN1 BAZ1B CHD8 HEATR1 XPO1 SRBD1 CREBBP YWHAE SRRT RIF1 FANCI VPS35 EXOC1 ATP2A2 PALLD SON | 7.36e-11 | 1353 | 239 | 34 | 29467282 |
| Pubmed | RPN2 RPS2 USP9X PABPC4 STK38 CCDC47 NCAPD2 SEC16A C1QBP FAM135A HSPA5 MPP7 NCK2 CAD CARMIL1 XPO1 STAM YWHAE JMJD1C PDIA4 FANCI CRYBG3 ATP2A2 PALLD | 1.71e-10 | 708 | 239 | 24 | 39231216 | |
| Pubmed | RPS2 USP9X PABPC4 DAPK3 NCL STRN HSPA12A NF1 ATP8A1 SBF1 SACS SEC16A IQSEC1 SIPA1L2 HSPA5 NCK2 STRN3 CAD KRT19 SYNE1 CARMIL1 EFHD2 NBEA XPO1 YWHAE MADD SRRT VPS35 EXOC1 SSH2 ATP2A2 ATP2B2 ATP2B4 PCM1 | 3.19e-10 | 1431 | 239 | 34 | 37142655 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | ACP6 KNTC1 MYCBP2 RPN2 USP9X PABPC4 EHD4 RTF1 PTPN3 STRN CCDC47 PIN1 CHST12 CAB39L MMS19 CPSF2 STRN3 PUF60 XPO4 HEATR1 ODC1 JMJD1C PDIA4 PPP4R3B SRRT IBTK LOXHD1 FANCI VPS35 STK38L ATP2A2 SON | 3.47e-10 | 1284 | 239 | 32 | 17353931 |
| Pubmed | KDM5B MYCBP2 USP9X USP9Y RYR3 CEP350 PTPRD OTOF SACS CHD6 MERTK HSD17B4 HECTD1 HSPA5 SYNE1 APEH NBEA OAZ1 STAM NR1D1 CREBBP YWHAE MADD VPS9D1 PPP4R3B THOP1 FBH1 EXOC1 ZNF84 ATP2A2 PCM1 PCNT | 3.54e-10 | 1285 | 239 | 32 | 35914814 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | KDM5B MYCBP2 RPN2 RPS2 STK38 NCL USP9Y SBF1 SACS PCDH15 IQSEC1 C1QBP USP12 PDIA5 CHD6 CPSF2 HSD17B4 SIPA1L2 HSPA5 CAD PUF60 SYNE1 B3GALT6 PCDHA1 XPO1 SRRT RBM6 ATP2A2 SON | 4.84e-10 | 1082 | 239 | 29 | 38697112 |
| Pubmed | MYCBP2 USP9X DAPK3 NCL KIAA0319 STRN NF1 PTPRD SBF1 SEC16A DIAPH2 IQSEC1 CPSF2 TAF5 MGA STRN3 CAD SYNE1 EFHD2 CHD8 NBEA YWHAE RAB3IP SSH2 ATP2B4 PCM1 PCNT | 7.66e-10 | 963 | 239 | 27 | 28671696 | |
| Pubmed | MYCBP2 RPN2 NCL KIAA0753 EHD4 HSPA12A SBF1 PMPCA SACS CCDC47 PEX19 C1QBP PDIA5 TACC1 SIPA1L2 FAM135A HSPA5 MPP7 CAD OFD1 CALU SYNE1 BAZ1B APEH CEP192 HEATR1 PDIA4 VPS35 CRYBG3 DAAM1 ATP2A2 ATP2B4 PCM1 PCNT | 8.57e-10 | 1487 | 239 | 34 | 33957083 | |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | KNTC1 USP9X RABGAP1 STRN SEC16A AGFG1 SIPA1L2 FAM135A NCK2 CAD KRT19 BAZ1B CEP192 CREBBP PPP4R3B RBM6 CRYBG3 TOPORS CFAP44 PCM1 PCNT | 9.90e-10 | 588 | 239 | 21 | 38580884 |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | RPS2 PABPC4 STK38 MCM6 NCL C1QBP MMS19 CPSF2 HSD17B4 HSPA5 CAD PUF60 CALU SYNE1 EFHD2 HEATR1 XPO1 YWHAE ZCCHC3 MADD SRRT RBM6 SON | 1.11e-09 | 714 | 239 | 23 | 28302793 |
| Pubmed | SETD1A RPN2 USP9X PABPC4 NPM3 SEC16A C1QBP USP12 CHD6 CPSF2 TAF5 MGA CAD OFD1 CALU BAZ1B CHD8 CEP192 PPARG CREBBP JMJD1C ZCCHC3 PDIA4 SRRT RSBN1 RIF1 CHD5 PAXIP1 RBM6 ZFHX3 PABPC1L ATP2A2 PCM1 | 1.22e-09 | 1429 | 239 | 33 | 35140242 | |
| Pubmed | USP9X PABPC4 NCL SBF1 SACS SEC16A PEX19 TACC1 TENT5A GTSE1 R3HCC1 BAZ1B CHD8 CREBBP PCM1 SON | 1.58e-09 | 332 | 239 | 16 | 37433992 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | KNTC1 RPN2 NCL ITGB4 SBF1 NCAPD2 SEC16A MMS19 HECTD1 CAD XPO1 MTTP ATP2A2 | 1.76e-09 | 202 | 239 | 13 | 33005030 |
| Pubmed | SETD1A MYCBP2 USP9X NCAPD2 SEC16A TAB1 TAF5 MGA HSPA5 CAD PUF60 BAZ1B EFHD2 CHD8 HEATR1 CREBBP JMJD1C PHF3 PALLD PCM1 | 1.80e-09 | 549 | 239 | 20 | 38280479 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYCBP2 RPS2 USP9X PABPC4 STK38 MCM6 NCL NPM3 S100A11 NCAPD2 SEC16A PEX19 AGFG1 C1QBP MMS19 TAB1 HSPA5 STRN3 CAD PUF60 CALU EFHD2 XPO1 YWHAE PDIA4 FANCI VPS35 STK38L ATP2A2 | 1.89e-09 | 1149 | 239 | 29 | 35446349 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | KNTC1 RPS2 USP9X PABPC4 MCM6 NCL RABGAP1 NPM3 EHD4 RTF1 NCAPD2 SEC16A AGFG1 C1QBP MMS19 HECTD1 HSPA5 STRN3 PUF60 CALU CAPN1 APEH EFHD2 XPO1 YWHAE PDIA4 PPP4R3B SRRT LIG1 THOP1 FANCI VPS35 TRIM47 | 1.91e-09 | 1455 | 239 | 33 | 22863883 |
| Pubmed | KNTC1 USP9X KIAA0753 STRN NF1 SEC16A C1QBP TAB1 SIPA1L2 HECTD1 MPP7 STRN3 OFD1 CEP192 STAM YWHAE STK38L PCM1 | 2.45e-09 | 446 | 239 | 18 | 24255178 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MYCBP2 PABPC4 CEP350 PMPCA PEX19 C1QBP HSD17B4 HECTD1 SLC27A2 STRN3 OFD1 CAPN1 GTSE1 XPO4 HEATR1 CCDC51 PDIA4 IBTK FANCI MPHOSPH10 ATP2B4 PCM1 PCNT | 3.12e-09 | 754 | 239 | 23 | 33060197 |
| Pubmed | PABPC4 TTF1 NPM3 STRN SBF1 CCDC47 NCAPD2 CHD6 CPSF2 TAF5 MPP7 STRN3 CAD SYNE1 BAZ1B EFHD2 CHD8 HEATR1 SRBD1 YWHAE MYLK2 SRRT RSBN1 RIF1 UTP25 PHF3 RBM6 CD58 ZFHX3 MPHOSPH10 DAAM1 ATP2A2 SON | 3.84e-09 | 1497 | 239 | 33 | 31527615 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | CLGN RPN2 MCM6 NCL PTPN3 PTPN6 PTPRD SBF1 PMPCA SEC16A PEX19 TAB1 SIPA1L2 HECTD1 HSPA5 MPP7 XPO4 EFHD2 HEATR1 XPO1 YWHAE PDIA4 THOP1 FANCI VPS35 PCM1 | 4.44e-09 | 974 | 239 | 26 | 28675297 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | MYCBP2 PDPK1 NCL S100A11 NF1 SEC16A IQSEC1 CPSF2 STRN3 CARMIL1 GTSE1 BAZ1B XPO1 NR1D1 SRRT LIG1 RIF1 PHF3 RBM6 TOPORS ATP2A2 PCM1 SON | 5.09e-09 | 774 | 239 | 23 | 15302935 |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | KIF18A RPN2 RPS2 MCM6 NCL NPM3 RTF1 S100A11 HSPA5 CALU ZNF280C BAZ1B HEATR1 XPO1 SRBD1 JMJD1C SRRT LIG1 RIF1 UTP25 PHF3 FANCI RBM6 MPHOSPH10 ATP2A2 SON | 6.07e-09 | 989 | 239 | 26 | 36424410 |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | KIAA0753 CEP350 SEC16A SCN9A DCLRE1A MGA OFD1 GTSE1 CEP192 JMJD1C PALLD PCM1 | 6.47e-09 | 184 | 239 | 12 | 32908313 |
| Pubmed | Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. | 6.91e-09 | 84 | 239 | 9 | 25670202 | |
| Pubmed | KNTC1 CLGN MYCBP2 CEP350 CCDC47 SEC16A PEX19 AGFG1 DCLRE1A TACC1 CHD6 CPSF2 MGA HECTD1 NCK2 EFHD2 JMJD1C MADD PDIA4 IBTK PHF3 PCM1 | 9.33e-09 | 733 | 239 | 22 | 34672954 | |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | USP9X PABPC4 USP9Y STRN SEC16A MMS19 HECTD1 HSPA5 NCK2 STRN3 CAD HEATR1 CREBBP YWHAE FANCI VPS35 ATP2A2 | 1.00e-08 | 432 | 239 | 17 | 23455922 |
| Pubmed | SCN3A CHD6 CPSF2 SIPA1L2 TRMT5 FAM135A JMJD1C PPP4R3B IBTK CHD5 MINDY1 | 1.01e-08 | 153 | 239 | 11 | 10718198 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | SETD1A RPN2 RPS2 PABPC4 MCM6 NCL TTF1 NPM3 CCDC47 SEC16A IQSEC1 C1QBP CHD6 CPSF2 TAF5 HSD17B4 HSPA5 CAD KRT19 PUF60 BAZ1B CHD8 HEATR1 ZCCHC3 PPP4R3B RSBN1 LIG1 MPHOSPH10 ATP2A2 SON | 1.03e-08 | 1318 | 239 | 30 | 30463901 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | PABPC4 NCL SEC16A AGFG1 C1QBP MGA HSPA5 PUF60 GTSE1 ZNF280C BAZ1B CHD8 HEATR1 YWHAE JMJD1C SRRT RSBN1 RIF1 PHF3 FANCI RBM6 MPHOSPH10 ATP2A2 PCM1 SON | 1.29e-08 | 954 | 239 | 25 | 36373674 |
| Pubmed | RPS2 USP9X MCM6 NCL C1QBP MMS19 HSPA5 CAD XPO1 YWHAE FANCI ATP2A2 | 1.39e-08 | 197 | 239 | 12 | 31620119 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KNTC1 RPN2 RPS2 USP9X PABPC4 MCM6 NCL NPM3 EHD4 NF1 PMPCA CCDC47 NCAPD2 C1QBP HSD17B4 HSPA5 CAD PUF60 CALU SYNE1 ZNF280C BAZ1B HEATR1 XPO1 YWHAE PDIA4 SRRT RIF1 FANCI VPS35 ATP2A2 | 1.62e-08 | 1425 | 239 | 31 | 30948266 |
| Pubmed | 1.80e-08 | 66 | 239 | 8 | 23472066 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EPHB2 KIF18A CLGN MYCBP2 RPN2 TMTC2 RABGAP1 ITGB4 NF1 CCDC47 PIN1 C1QBP PDIA5 CHST12 CPSF2 HECTD1 HSPA5 CALU B3GALT6 YWHAE MADD PDIA4 MST1R FANCI VPS35 CD58 ATP2A2 PALLD | 2.01e-08 | 1201 | 239 | 28 | 35696571 |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | RPN2 PABPC4 CEP350 PTPN3 STRN PTPN6 SEC16A MPP7 STRN3 CAD CALU SYNE1 XPO1 YWHAE PDIA4 PPP4R3B RIF1 FANCI ATP2A2 | 2.10e-08 | 573 | 239 | 19 | 28330616 |
| Pubmed | MYCBP2 PDPK1 HSPA12A NF1 ATP8A1 SACS IQSEC1 SIPA1L2 NBEA MADD RAB3IP VPS35 ATP2A2 ATP2B2 PCM1 | 2.21e-08 | 347 | 239 | 15 | 17114649 | |
| Pubmed | Functional genomic landscape of cancer-intrinsic evasion of killing by T cells. | KIF18A USP9X VPS33A RTF1 CEP350 NCAPD2 PEX19 TRMT5 MGA CAD ZFAT MAU2 HEATR1 CREBBP VPS35 PAXIP1 PCNT | 2.28e-08 | 457 | 239 | 17 | 32968282 |
| Pubmed | LGALS3BP regulates centriole biogenesis and centrosome hypertrophy in cancer cells. | RPS2 USP9X NCL CEP350 STRN SBF1 SEC16A C1QBP SIPA1L2 HECTD1 HSPA5 STRN3 CAD PUF60 CALU CAPN1 CEP192 YWHAE FANCI PCM1 | 2.28e-08 | 639 | 239 | 20 | 23443559 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EPHB2 RPN2 RPS2 USP9X FAM114A2 MCM6 NCL RABGAP1 EHD4 S100A11 NLN MTUS1 CCDC47 NCAPD2 SEC16A C1QBP HSD17B4 HSPA5 PUF60 CALU CAPN1 APEH EFHD2 XPO1 YWHAE PDIA4 EXOC1 ATP2A2 PALLD SON | 2.32e-08 | 1367 | 239 | 30 | 32687490 |
| Pubmed | RPN2 USP9X PABPC4 MCM6 NCL NPM3 EHD4 S100A11 SEC16A C1QBP MMS19 TAB1 HSPA5 CAD KRT19 PUF60 CALU SYNE1 CAPN1 HEATR1 XPO1 YWHAE PALLD | 2.51e-08 | 844 | 239 | 23 | 25963833 | |
| Pubmed | RPS2 CEP350 MTUS1 SEC16A SIPA1L2 HECTD1 OFD1 CEP192 IBTK CRYBG3 PALLD PCM1 | 2.69e-08 | 209 | 239 | 12 | 36779422 | |
| Pubmed | USP9X KIAA0753 AGFG1 TAB1 MGA OFD1 STAM ZCCHC3 IBTK PALLD PCM1 | 2.85e-08 | 169 | 239 | 11 | 31462741 | |
| Pubmed | RPN2 USP9X PABPC4 MCM6 EHD4 RTF1 C1QBP PDIA5 MMS19 HSPA5 PUF60 CALU BAZ1B XPO1 PDIA4 SRRT RSBN1 RIF1 VPS35 PALLD | 3.26e-08 | 653 | 239 | 20 | 33742100 | |
| Pubmed | KIF18A MYCBP2 PABPC4 TTF1 RYR2 STRN PEX19 CHD6 MERTK MGA TENT5A STAM CREBBP VPS35 PAXIP1 MPHOSPH10 DAAM1 TOPORS SON | 3.41e-08 | 591 | 239 | 19 | 15231748 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MYCBP2 RPS2 DAPK3 NCL RABGAP1 EHD4 STRN PMPCA CCDC47 SEC16A PEX19 C1QBP MMS19 TACC1 TAB1 HSD17B4 TRMT5 STRN3 CAD SYNE1 HEATR1 CCDC51 YWHAE ZCCHC3 PDIA4 IBTK MPHOSPH10 CRYBG3 ATP2A2 SON PCNT | 4.85e-08 | 1496 | 239 | 31 | 32877691 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | RPN2 RPS2 USP9X PABPC4 MCM6 NCL NPM3 RTF1 CCDC47 NCAPD2 SEC16A C1QBP HSD17B4 HECTD1 HSPA5 CAD PUF60 CARMIL1 EFHD2 XPO1 CCDC51 YWHAE SRRT RIF1 THOP1 VPS35 TRIM47 ATP2A2 PALLD SON | 4.96e-08 | 1415 | 239 | 30 | 28515276 |
| Pubmed | STK38 NCL TAB1 MGA HSPA5 CAD MAU2 XPO1 RIF1 RBM6 STK38L ATP2A2 PALLD | 6.12e-08 | 272 | 239 | 13 | 31010829 | |
| Pubmed | 7.49e-08 | 7 | 239 | 4 | 20962236 | ||
| Pubmed | KIF18A WIPF3 COL22A1 DTX3L KIAA0753 CEP350 STRN SBF1 CCDC47 MMS19 PLEKHH2 MGA STRN3 APEH EFHD2 XPO1 ZCCHC3 MADD PHF3 SSH2 | 7.78e-08 | 689 | 239 | 20 | 36543142 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | KIF18A MYCBP2 RPS2 PABPC4 NCL TTF1 HECTD1 BAZ1B B3GALT6 HEATR1 XPO1 SRBD1 ZCCHC3 SRRT RSBN1 IBTK RIF1 PHF3 RBM6 MPHOSPH10 SON | 8.13e-08 | 759 | 239 | 21 | 35915203 |
| Pubmed | MYCBP2 RPS2 USP9X VPS33A NCL RABGAP1 RYR2 RPS6KC1 STRN HSPA12A NF1 PEX19 IQSEC1 TACC1 TAB1 SIPA1L2 STRN3 CAD NBEA YWHAE MADD EXOC1 CRYBG3 DAAM1 ATP2A2 PCM1 | 1.01e-07 | 1139 | 239 | 26 | 36417873 | |
| Pubmed | RPN2 RPS2 USP9X MCM6 NCAPD2 C1QBP HSD17B4 HECTD1 HSPA5 CAD PUF60 HEATR1 XPO1 YWHAE RIF1 FANCI VPS35 ATP2A2 SON | 1.12e-07 | 638 | 239 | 19 | 33239621 | |
| Pubmed | RPS2 PABPC4 NCL RYR2 CEP350 PTPN3 SEC16A C1QBP DCLRE1A TACC1 MGA FAM135A KRT19 APEH NBEA CEP192 DNAH7 LIG1 RIF1 ZFHX3 PCM1 | 1.20e-07 | 777 | 239 | 21 | 35844135 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | SETD1A USP9X PABPC4 NCL S100A11 CCDC47 PIN1 NCAPD2 SEC16A C1QBP PDIA5 CPSF2 MERTK FAM135A NCK2 CAD KRT19 PPARG YWHAE SRRT RAB3IP PAXIP1 MPHOSPH10 | 1.23e-07 | 922 | 239 | 23 | 27609421 |
| Pubmed | Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. | USP9X RYR2 RYR3 PCDH15 MMS19 HSPA5 VIPR1 CALU XPO1 CCDC51 ATP2A2 | 1.23e-07 | 195 | 239 | 11 | 17110338 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | SETD1A EHD4 NCAPD2 CPSF2 TRMT5 BAZ1B CHD8 SRBD1 JMJD1C SRRT RSBN1 RIF1 FANCI PAXIP1 | 1.24e-07 | 341 | 239 | 14 | 32971831 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | PABPC4 MCM6 ITGB4 NCAPD2 SEC16A C1QBP MMS19 HSD17B4 HSPA5 CAD CALU XPO4 XPO1 YWHAE PDIA4 PABPC1L DAAM1 ATP2A2 ATP2B4 | 1.39e-07 | 647 | 239 | 19 | 26618866 |
| Pubmed | 1.49e-07 | 8 | 239 | 4 | 11784029 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 1.49e-07 | 8 | 239 | 4 | 19033399 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | MYCBP2 RABGAP1 FOXN3 TTF1 ANKAR PDIA5 CAB39L CHD6 HECTD1 NCK2 VIPR1 CARMIL1 CAPN1 CEP192 CREBBP YWHAE JMJD1C ZBTB46 THOP1 THRA RAB3IP RBM6 CAMKMT ZFHX3 ZNF84 DAAM1 STK38L ICA1L PCM1 PCNT | 1.49e-07 | 1489 | 239 | 30 | 28611215 |
| Pubmed | CLGN USP9X PABPC4 NF1 CCDC47 NCAPD2 SEC16A MMS19 MGA HSPA5 XPO4 HEATR1 XPO1 RIF1 ELMO2 FANCI RBM6 STK38L ATP2A2 | 1.76e-07 | 657 | 239 | 19 | 36180527 | |
| Pubmed | SPATA2-Mediated Binding of CYLD to HOIP Enables CYLD Recruitment to Signaling Complexes. | STK38 NCL SEC16A IQSEC1 CARD6 TAB1 CPSF2 MGA HSPA5 CAD KRT19 CALU YWHAE PCM1 | 1.88e-07 | 353 | 239 | 14 | 27545878 |
| Pubmed | Quantitative interactome proteomics identifies a proteostasis network for GABAA receptors. | 2.25e-07 | 125 | 239 | 9 | 36030824 | |
| Pubmed | Proximity Mapping of CCP6 Reveals Its Association with Centrosome Organization and Cilium Assembly. | 2.27e-07 | 38 | 239 | 6 | 36674791 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 2.27e-07 | 38 | 239 | 6 | 30786075 | |
| Pubmed | CLGN RPN2 RPS2 USP9X PABPC4 NCL NCAPD2 C1QBP TAB1 HSPA5 CAD BAZ1B HEATR1 XPO1 YWHAE VPS35 | 2.94e-07 | 484 | 239 | 16 | 31995728 | |
| Pubmed | NCL ITGB4 CEP350 PTPN3 DIAPH2 AGFG1 CHD6 MGA HSPA5 KRT19 SYNE1 CHD8 CREBBP YWHAE MADD RIF1 | 3.10e-07 | 486 | 239 | 16 | 20936779 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 18403125 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 18434746 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 3.20e-07 | 3 | 239 | 3 | 9204703 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 21881589 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 3.20e-07 | 3 | 239 | 3 | 12213830 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 25239916 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 11159936 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 7959768 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 7635066 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 7876312 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 3.20e-07 | 3 | 239 | 3 | 10788707 | |
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 3.20e-07 | 3 | 239 | 3 | 7621815 | |
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 3.20e-07 | 3 | 239 | 3 | 10473538 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 9242641 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 18643873 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 3.20e-07 | 3 | 239 | 3 | 4600883 | |
| Pubmed | RPS2 USP9X PABPC4 STK38 NCL SEC16A C1QBP TAB1 MGA HSPA5 CAD SRBD1 YWHAE ZCCHC3 SRRT RIF1 STK38L | 3.27e-07 | 551 | 239 | 17 | 34728620 | |
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | RPN2 RPS2 PABPC4 STK38 NCL C1QBP TAB1 HSPA5 DNAH3 CAPN1 YWHAE VPS35 STK38L | 3.56e-07 | 317 | 239 | 13 | 17620599 |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 4.13e-07 | 175 | 239 | 10 | 25756610 | |
| Pubmed | KIF18A IQSEC1 DCLRE1A HSD17B4 MGA GTSE1 CREBBP MLH3 FANCI PAXIP1 RBM6 | 4.52e-07 | 222 | 239 | 11 | 37071664 | |
| Pubmed | RPN2 RPS2 USP9X PABPC4 STK38 NCL USP9Y NPM3 SCN3A NCAPD2 C1QBP CHD6 HSPA5 CAD KRT19 PUF60 CHD8 CEP192 DNAH7 YWHAE ZCCHC3 PDIA4 CHD5 PABPC1L STK38L | 4.68e-07 | 1153 | 239 | 25 | 29845934 | |
| Pubmed | FIP200 controls the TBK1 activation threshold at SQSTM1/p62-positive condensates. | RPN2 RPS2 PABPC4 CCDC47 SEC16A OFD1 KRT19 ZCCHC3 TOPORS ATP2A2 PCM1 | 4.73e-07 | 223 | 239 | 11 | 34226595 |
| Interaction | SIRT7 interactions | MYCBP2 RPN2 RPS2 USP9X PABPC4 MCM6 NCL TTF1 NF1 SBF1 NCAPD2 SEC16A HECTD1 CAD PUF60 CAPN1 BAZ1B CHD8 HEATR1 XPO1 PPARG ZCCHC3 PDIA4 RIF1 UTP25 PHF3 FANCI RBM6 MPHOSPH10 ATP2A2 PCM1 SON PCNT | 5.42e-11 | 744 | 237 | 33 | int:SIRT7 |
| Interaction | YWHAH interactions | KDM5B MYCBP2 PDPK1 DAPK3 KIAA0753 CEP350 PTPN3 NF1 SBF1 MTUS1 SEC16A AGFG1 C1QBP USP12 DCLRE1A TAB1 SIPA1L2 HECTD1 OFD1 KRT19 CARMIL1 GTSE1 CEP192 XPO1 CREBBP DNAH7 YWHAE MADD PDIA4 MST1R SRRT THRA PHF3 PLEKHM3 SSH2 CRYBG3 PALLD PCM1 PCNT | 6.48e-10 | 1102 | 237 | 39 | int:YWHAH |
| Interaction | YWHAG interactions | KDM5B MYCBP2 RPS2 PDPK1 PABPC4 DAPK3 KIAA0753 CEP350 PTPN3 NF1 SBF1 MTUS1 SEC16A IQSEC1 AGFG1 C1QBP USP12 TAB1 SIPA1L2 HECTD1 CAD KRT19 PUF60 CARMIL1 GTSE1 OAZ1 CEP192 XPO1 PPARG DNAH7 YWHAE MYLK2 PDIA4 MST1R ELMO2 PHF3 PLEKHM3 SSH2 PCM1 SON | 6.49e-09 | 1248 | 237 | 40 | int:YWHAG |
| Interaction | RB1CC1 interactions | RPN2 RPS2 PABPC4 EHD4 HSPA12A CCDC47 SEC16A TACC1 OFD1 KRT19 CREBBP YWHAE ZCCHC3 MADD TIPARP EXOC1 TOPORS ATP2A2 PALLD PCM1 | 3.59e-08 | 387 | 237 | 20 | int:RB1CC1 |
| Interaction | PFN1 interactions | KNTC1 WIPF3 NCL RABGAP1 CEP350 NF1 ATP8A1 SEC16A DIAPH2 SIPA1L2 HECTD1 FAM135A NCK2 VIPR1 STRN3 CARMIL1 NBEA CEP192 PDIA4 CHD5 CRYBG3 PALLD PCNT | 3.92e-08 | 509 | 237 | 23 | int:PFN1 |
| Interaction | SIRT6 interactions | SETD1A MYCBP2 RPS2 USP9X MCM6 NCL RPS6KC1 NF1 SBF1 NCAPD2 SEC16A C1QBP MMS19 HECTD1 CAD CHD8 PPARG CREBBP PPP4R3B SRRT UTP25 PHF3 RBM6 MPHOSPH10 PALLD | 1.14e-07 | 628 | 237 | 25 | int:SIRT6 |
| Interaction | CCDC8 interactions | MYCBP2 RPS2 USP9X PABPC4 MCM6 NCL EHD4 CEP350 NF1 SACS SEC16A HSD17B4 HECTD1 HSPA5 CAD OFD1 GTSE1 BAZ1B HEATR1 XPO1 YWHAE PDIA4 ATP2A2 PCM1 PCNT | 2.58e-07 | 656 | 237 | 25 | int:CCDC8 |
| Interaction | CCDC6 interactions | USP9X RABGAP1 STRN PIN1 SEC16A SIPA1L2 FAM135A HSPA5 NCK2 CAD KRT19 CEP192 XPO1 YWHAE PPP4R3B EXOC1 | 3.03e-07 | 286 | 237 | 16 | int:CCDC6 |
| Interaction | YWHAQ interactions | KDM5B MYCBP2 PDPK1 PABPC4 DAPK3 NCL ITGB4 CEP350 PTPN3 NF1 SBF1 MTUS1 AGFG1 C1QBP TAB1 MERTK SIPA1L2 HECTD1 SLC27A2 CAD KRT19 CALU CAPN1 GTSE1 CEP192 DNAH7 YWHAE MYLK2 MST1R PPP4R3B THRA PLEKHM3 SSH2 PCM1 | 3.53e-07 | 1118 | 237 | 34 | int:YWHAQ |
| Interaction | KCNA3 interactions | RPN2 RPS2 USP9X SPEF2 PABPC4 STK38 RYR1 CCDC47 NCAPD2 SEC16A C1QBP FAM135A HSPA5 MPP7 NCK2 CAD PUF60 CARMIL1 AKNAD1 XPO1 STAM YWHAE JMJD1C PDIA4 PHF3 FANCI CRYBG3 ATP2A2 PALLD | 4.55e-07 | 871 | 237 | 29 | int:KCNA3 |
| Interaction | ANKRD55 interactions | RPS2 USP9X MCM6 NCL C1QBP MMS19 HSPA5 NCK2 CAD XPO1 YWHAE IFT52 FANCI ATP2A2 | 5.58e-07 | 228 | 237 | 14 | int:ANKRD55 |
| Interaction | HECTD1 interactions | EPHB2 KIF18A MYCBP2 RPS2 USP9X PABPC4 NCL TTF1 EHD4 NCAPD2 CPSF2 HECTD1 BAZ1B B3GALT6 HEATR1 XPO1 SRBD1 YWHAE ZCCHC3 TIPARP SRRT RSBN1 IBTK RIF1 PHF3 RBM6 CAMKMT EXOC1 MPHOSPH10 SSH2 SON | 5.82e-07 | 984 | 237 | 31 | int:HECTD1 |
| Interaction | GSK3A interactions | RPS2 PABPC4 CEP350 MTUS1 PIN1 SEC16A SIPA1L2 HECTD1 HSPA5 OFD1 PUF60 CEP192 SRBD1 YWHAE TIPARP IBTK CRYBG3 TOPORS PALLD PCM1 | 6.60e-07 | 464 | 237 | 20 | int:GSK3A |
| Interaction | PPIA interactions | ACP6 RPS2 SPEF2 PABPC4 STK38 RTF1 NLN STRN PIN1 SEC16A TACC1 CPSF2 HSD17B4 HSPA5 STRN3 GTSE1 ZNF280C CHD8 HEATR1 STAM SRBD1 YWHAE RSBN1 LIG1 RIF1 PHF3 PAXIP1 MPHOSPH10 CRYBG3 | 6.76e-07 | 888 | 237 | 29 | int:PPIA |
| Interaction | LRRC31 interactions | KNTC1 RPN2 NCL ITGB4 SBF1 NCAPD2 SEC16A MMS19 HECTD1 CAD XPO1 MTTP ATP2A2 | 9.92e-07 | 205 | 237 | 13 | int:LRRC31 |
| Interaction | CPAP interactions | KIAA0753 SEC16A IQSEC1 STRN3 OFD1 CEP192 CREBBP YWHAE IBTK PALLD PCM1 PCNT | 1.73e-06 | 182 | 237 | 12 | int:CPAP |
| Interaction | CD274 interactions | USP9X FAM114A2 MCM6 NF1 SEC16A PEX19 C1QBP TAB1 HSD17B4 CAPN1 XPO4 HEATR1 XPO1 YWHAE SRRT EXOC1 ATP2A2 | 1.91e-06 | 369 | 237 | 17 | int:CD274 |
| Interaction | CNTRL interactions | VPS33A DAPK3 KIAA0753 CEP350 HSPA5 OFD1 GTSE1 CEP192 CREBBP PDIA4 PCM1 PCNT | 3.20e-06 | 193 | 237 | 12 | int:CNTRL |
| Interaction | CTAGE1 interactions | 3.70e-06 | 10 | 237 | 4 | int:CTAGE1 | |
| Interaction | AMOT interactions | USP9X KIAA0753 CEP350 PIN1 SEC16A SIPA1L2 HECTD1 MPP7 OFD1 KRT19 CEP192 RIF1 THRA CRYBG3 PCNT | 4.67e-06 | 312 | 237 | 15 | int:AMOT |
| Interaction | NUP43 interactions | SETD1A CCDC168 CSMD3 TTF1 RYR2 RTF1 ATP8A1 PIN1 CHD6 MGA ZNF280C CHD8 HEATR1 JMJD1C SRRT RSBN1 RIF1 FANCI MTTP ZFHX3 MPHOSPH10 SON | 5.07e-06 | 625 | 237 | 22 | int:NUP43 |
| Interaction | WDR5 interactions | SETD1A RPN2 RPS2 PDPK1 PABPC4 NCL RTF1 SBF1 CCDC47 IQSEC1 PDIA5 CPSF2 HSD17B4 MGA HECTD1 HSPA5 SLC27A2 KRT19 PUF60 CHD8 MAU2 HEATR1 XPO1 CREBBP ZCCHC3 TIPARP PDIA4 SRRT VPS35 PAXIP1 ATP2A2 | 5.96e-06 | 1101 | 237 | 31 | int:WDR5 |
| Interaction | ILK interactions | ACP6 PDPK1 ITGB4 CCDC47 SEC16A MMS19 NCK2 CAD PUF60 CALU HEATR1 XPO1 POSTN FANCI ATP2A2 | 6.10e-06 | 319 | 237 | 15 | int:ILK |
| Interaction | ECT2 interactions | MYCBP2 RPS2 USP9X DAPK2 PABPC4 MCM6 NCL USP9Y STRN CCDC47 NCAPD2 SEC16A C1QBP CPSF2 HSD17B4 HECTD1 OFD1 PUF60 CAPN1 HEATR1 MADD TIPARP SRRT MYO1F PABPC1L ATP2A2 SON | 6.23e-06 | 887 | 237 | 27 | int:ECT2 |
| Interaction | TPTE2 interactions | 6.57e-06 | 84 | 237 | 8 | int:TPTE2 | |
| Interaction | CDC27 interactions | KIF18A PABPC4 NCL PIN1 TAF5 HECTD1 CHD8 XPO1 CREBBP RSBN1 ELMO2 PAXIP1 FBXO43 | 8.45e-06 | 249 | 237 | 13 | int:CDC27 |
| Interaction | SPATA2 interactions | 8.54e-06 | 87 | 237 | 8 | int:SPATA2 | |
| Interaction | C3orf18 interactions | 8.81e-06 | 115 | 237 | 9 | int:C3orf18 | |
| Interaction | YWHAB interactions | KDM5B MYCBP2 PDPK1 PABPC4 STK38 DAPK3 ITGB4 CEP350 PTPN3 NF1 C1QBP USP12 TAB1 MERTK SIPA1L2 HECTD1 HSPA5 CEP192 STAM PPARG YWHAE PDIA4 MST1R PHF3 PLEKHM3 SSH2 STK38L PCM1 SON | 9.12e-06 | 1014 | 237 | 29 | int:YWHAB |
| Interaction | NTRK3 interactions | CLGN RPN2 EHD4 CCDC47 AGFG1 TACC1 FAM135A HSPA5 MPP7 NCK2 NBEA XPO1 STAM PDIA4 FANCI ATP2A2 | 9.83e-06 | 374 | 237 | 16 | int:NTRK3 |
| Interaction | CEP350 interactions | KIAA0753 CEP350 OFD1 KRT19 CEP192 XPO1 PPARG TIPARP PCM1 PCNT | 1.10e-05 | 149 | 237 | 10 | int:CEP350 |
| Interaction | TNIK interactions | EPHB2 MYCBP2 USP9X STRN PTPRD IQSEC1 TAF5 MGA NCK2 STRN3 CAD SYNE1 CHD8 NBEA XPO1 PCM1 | 1.24e-05 | 381 | 237 | 16 | int:TNIK |
| Interaction | GSK3B interactions | RPS2 PDPK1 MCM6 NCL DTX3L CEP350 MTUS1 SEC16A CHD6 TAB1 HSD17B4 SIPA1L2 HECTD1 HSPA5 CAD OFD1 CAPN1 APEH CEP192 XPO1 PDIA4 IBTK VPS35 CRYBG3 PALLD PCM1 | 1.24e-05 | 868 | 237 | 26 | int:GSK3B |
| Interaction | DNAJC7 interactions | PABPC4 KIAA0753 EHD4 NF1 SBF1 SACS SEC16A IQSEC1 HSPA5 CAD OFD1 APEH MAU2 PPARG TIPARP CD58 PCNT | 1.24e-05 | 425 | 237 | 17 | int:DNAJC7 |
| Interaction | FBXO42 interactions | USP9X RABGAP1 SEC16A AGFG1 TAB1 FAM135A CAD CEP192 CRYBG3 CFAP44 ATP2A2 PCM1 PCNT | 1.29e-05 | 259 | 237 | 13 | int:FBXO42 |
| Interaction | GABRA1 interactions | 1.31e-05 | 152 | 237 | 10 | int:GABRA1 | |
| Interaction | MEX3A interactions | USP9X PABPC4 NCL SBF1 SACS SEC16A PEX19 TACC1 TENT5A GTSE1 R3HCC1 BAZ1B CHD8 CREBBP PCM1 SON | 1.36e-05 | 384 | 237 | 16 | int:MEX3A |
| Interaction | ATG5 interactions | PDPK1 DAPK2 RABGAP1 SBF1 PMPCA SACS SEC16A HSD17B4 CARMIL1 CAPN1 GTSE1 XPO1 NR1D1 CA5B ATP2B4 | 1.50e-05 | 344 | 237 | 15 | int:ATG5 |
| Interaction | KCTD13 interactions | RPS2 USP9X PABPC4 DAPK3 NCL STRN HSPA12A NF1 ATP8A1 SBF1 SACS SEC16A IQSEC1 SIPA1L2 HSPA5 NCK2 STRN3 CAD KRT19 SYNE1 CARMIL1 EFHD2 NBEA XPO1 PPARG YWHAE MADD SRRT VPS35 EXOC1 SSH2 ATP2A2 ATP2B2 ATP2B4 PCM1 | 1.71e-05 | 1394 | 237 | 35 | int:KCTD13 |
| Interaction | TRIM37 interactions | RPN2 PABPC4 NCL KIAA0753 CEP350 S100A11 SEC16A SCN9A DCLRE1A MGA HSPA5 OFD1 KRT19 GTSE1 CEP192 XPO1 PPARG JMJD1C ATP2A2 PALLD PCM1 | 1.90e-05 | 630 | 237 | 21 | int:TRIM37 |
| Interaction | LATS1 interactions | USP9X KIAA0753 CEP350 SEC16A TAB1 CPSF2 SIPA1L2 MGA CAD OFD1 CEP192 CREBBP YWHAE RIF1 RBM6 PCM1 PCNT | 1.94e-05 | 440 | 237 | 17 | int:LATS1 |
| Interaction | CSNK1E interactions | USP9X PDPK1 USP9Y KIAA0753 PTPRD SEC16A HECTD1 OFD1 GTSE1 XPO1 YWHAE TIPARP PCM1 FAM83A | 2.03e-05 | 311 | 237 | 14 | int:CSNK1E |
| Interaction | POU5F1 interactions | RPN2 USP9X NCL EHD4 NCAPD2 PCDH15 CPSF2 SIPA1L2 MGA CAD KRT19 CALU JMJD1C IBTK RIF1 PHF3 FANCI CHD5 PAXIP1 ZFHX3 | 2.05e-05 | 584 | 237 | 20 | int:POU5F1 |
| Interaction | SLC15A3 interactions | CLGN RPN2 CCDC47 PEX19 MMS19 SLC27A2 CAD HEATR1 XPO1 YWHAE FANCI ATP2A2 | 2.25e-05 | 234 | 237 | 12 | int:SLC15A3 |
| Interaction | CEP170 interactions | USP9X DAPK3 NCL KIAA0753 AGFG1 HECTD1 NCK2 OFD1 GTSE1 XPO1 YWHAE TIPARP RAB3IP PCM1 | 2.60e-05 | 318 | 237 | 14 | int:CEP170 |
| Interaction | SMG7 interactions | RPN2 RABGAP1 KIAA0753 SEC16A OFD1 KRT19 CHD8 XPO1 CREBBP JMJD1C CHD5 PAXIP1 RBM6 PCM1 | 2.69e-05 | 319 | 237 | 14 | int:SMG7 |
| Interaction | CDK7 interactions | RPN2 RPS2 STK38 NCL SEC16A C1QBP TAB1 TAF5 HSD17B4 MGA HSPA5 PUF60 CREBBP YWHAE PDIA4 RIF1 THRA ATP2B4 | 2.89e-05 | 501 | 237 | 18 | int:CDK7 |
| Interaction | PPEF1 interactions | 3.22e-05 | 52 | 237 | 6 | int:PPEF1 | |
| Interaction | MAGED2 interactions | MYCBP2 RPN2 NCL NPM3 PTPN6 C1QBP MMS19 HECTD1 HSPA5 XPO1 TIPARP SRRT | 3.26e-05 | 243 | 237 | 12 | int:MAGED2 |
| Interaction | EPHA8 interactions | 3.27e-05 | 169 | 237 | 10 | int:EPHA8 | |
| Interaction | CAMSAP2 interactions | 3.27e-05 | 169 | 237 | 10 | int:CAMSAP2 | |
| Interaction | EED interactions | KNTC1 MYCBP2 RPN2 RPS2 USP9X STK38 MCM6 NCL NPM3 NCAPD2 MMS19 CPSF2 HSD17B4 MGA HECTD1 HSPA5 KRT19 PUF60 CAPN1 ZNF280C BAZ1B XPO4 EFHD2 HEATR1 XPO1 SRRT LIG1 RIF1 THOP1 VPS35 MTTP ATP2A2 PCM1 SON PCNT | 3.61e-05 | 1445 | 237 | 35 | int:EED |
| Interaction | NCKAP5L interactions | 3.64e-05 | 106 | 237 | 8 | int:NCKAP5L | |
| Interaction | CEP120 interactions | 3.64e-05 | 106 | 237 | 8 | int:CEP120 | |
| Interaction | YAP1 interactions | SETD1A RPN2 RPS2 USP9X NCL RTF1 NF1 PIN1 SEC16A TAB1 TAF5 MGA HSPA5 CAD KRT19 CAPN1 BAZ1B EFHD2 CHD8 HEATR1 XPO1 NR1D1 CREBBP YWHAE JMJD1C TIPARP PHF3 PALLD MINDY1 | 3.77e-05 | 1095 | 237 | 29 | int:YAP1 |
| Interaction | ZYX interactions | USP9X CEP350 SEC16A SIPA1L2 FAM135A PUF60 APEH CEP192 XPO1 YWHAE TIPARP SSH2 CRYBG3 PCNT | 3.77e-05 | 329 | 237 | 14 | int:ZYX |
| Interaction | GIT1 interactions | 3.80e-05 | 172 | 237 | 10 | int:GIT1 | |
| Interaction | OPALIN interactions | KNTC1 NF1 PTPRD SBF1 USP12 MPP7 XPO4 HEATR1 FANCI ATP2B2 ATP2B4 | 3.91e-05 | 209 | 237 | 11 | int:OPALIN |
| Interaction | KRT18 interactions | KNTC1 MEIKIN PABPC4 KIAA0753 CEP350 SEC16A SIPA1L2 HECTD1 HSPA5 CAD OFD1 KRT19 CEP192 YWHAE CRYBG3 PCNT | 3.93e-05 | 419 | 237 | 16 | int:KRT18 |
| Interaction | ARAF interactions | RPN2 PABPC4 NCL MMS19 CHD6 HECTD1 HSPA5 CAD CALU HEATR1 XPO1 YWHAE TIPARP FANCI RAB3IP | 4.19e-05 | 376 | 237 | 15 | int:ARAF |
| Interaction | ACE2 interactions | RPN2 RPS2 PDPK1 PABPC4 MCM6 NCL RABGAP1 NPM3 S100A11 PTPN3 PTPRD NCAPD2 AGFG1 HSPA5 CAD PUF60 GTSE1 ZNF280C BAZ1B NBEA HEATR1 XPO1 CREBBP YWHAE PDIA4 SRRT RAB3IP VPS35 ATP2A2 | 4.51e-05 | 1106 | 237 | 29 | int:ACE2 |
| Interaction | FBXW11 interactions | KDM5B PABPC4 VPS33A FOXN3 NF1 SBF1 TACC1 MERTK PLEKHH2 SIPA1L2 HECTD1 CHD8 YWHAE ZBTB46 ELMO2 PALLD SON | 4.81e-05 | 473 | 237 | 17 | int:FBXW11 |
| Interaction | SLX4 interactions | KIF18A RPS2 MCM6 NCL CEP350 IQSEC1 DCLRE1A HSD17B4 MGA HSPA5 CAD GTSE1 CHD8 CREBBP MLH3 FANCI PAXIP1 RBM6 ATP2A2 | 5.01e-05 | 572 | 237 | 19 | int:SLX4 |
| Interaction | SMC5 interactions | PABPC4 NCL SEC16A AGFG1 C1QBP MGA HECTD1 HSPA5 PUF60 GTSE1 ZNF280C BAZ1B CHD8 HEATR1 YWHAE JMJD1C TIPARP SRRT RSBN1 RIF1 PHF3 FANCI RBM6 MPHOSPH10 ATP2A2 PCM1 SON | 5.14e-05 | 1000 | 237 | 27 | int:SMC5 |
| Interaction | RUFY1 interactions | RPN2 RPS2 USP9X FAM114A2 NCL NLN C1QBP HSPA5 CAD PUF60 XPO1 YWHAE MYLK2 TIPARP UTP25 RAB3IP ATP2A2 | 5.20e-05 | 476 | 237 | 17 | int:RUFY1 |
| Interaction | EFNB1 interactions | EPHB2 KNTC1 FAM114A2 NF1 SBF1 SACS MPP7 NCK2 XPO4 HEATR1 XPO1 PPP4R3B | 5.21e-05 | 255 | 237 | 12 | int:EFNB1 |
| Interaction | SEPTIN10 interactions | 5.31e-05 | 144 | 237 | 9 | int:SEPTIN10 | |
| Interaction | CEP152 interactions | KIAA0753 CEP350 SIPA1L2 OFD1 KRT19 CEP192 TIPARP PALLD PCM1 PCNT | 5.33e-05 | 179 | 237 | 10 | int:CEP152 |
| Interaction | XRN1 interactions | PABPC4 NPM3 KIAA0753 SEC16A HECTD1 OFD1 B3GALT6 CEP192 HEATR1 XPO1 TIPARP PCM1 | 5.83e-05 | 258 | 237 | 12 | int:XRN1 |
| Interaction | STK3 interactions | 5.85e-05 | 181 | 237 | 10 | int:STK3 | |
| Interaction | PCM1 interactions | MYCBP2 USP9X DAPK3 KIAA0753 CEP350 STRN OFD1 KRT19 ZNF280C CEP192 YWHAE TIPARP IBTK VPS35 PCM1 PCNT | 5.97e-05 | 434 | 237 | 16 | int:PCM1 |
| Interaction | BSG interactions | KNTC1 CLGN RPN2 HSPA12A CCDC47 NCAPD2 MMS19 TACC1 HSPA5 SLC27A2 CALU XPO4 HEATR1 STAM PDIA4 RIF1 EXOC1 ATP2A2 ATP2B2 ATP2B4 | 6.07e-05 | 631 | 237 | 20 | int:BSG |
| Interaction | GOLGA1 interactions | KIAA0753 CEP350 STRN MTUS1 SEC16A OFD1 CEP192 CRYBG3 PCM1 PCNT | 6.41e-05 | 183 | 237 | 10 | int:GOLGA1 |
| Interaction | OBSL1 interactions | RPS2 MCM6 NCL MYLK3 C1QBP CPSF2 SIPA1L2 MGA HECTD1 HSPA5 CAD PUF60 CALU SYNE1 BAZ1B HEATR1 XPO1 YWHAE PDIA4 SRRT RIF1 VPS35 PCM1 SON PCNT | 6.54e-05 | 902 | 237 | 25 | int:OBSL1 |
| Interaction | BRCA1 interactions | KNTC1 SETD1A KIF18A RPS2 USP9X PABPC4 MCM6 NCL CEP350 STRN NF1 PIN1 SEC16A DCLRE1A HSPA5 CAD APEH MAU2 XPO1 CREBBP YWHAE TIPARP PDIA4 RIF1 FANCI RAB3IP VPS35 RBM6 TRIM47 PALLD FAM83A | 6.76e-05 | 1249 | 237 | 31 | int:BRCA1 |
| Interaction | KRT8 interactions | USP9X MEIKIN KIAA0753 CEP350 NLN SEC16A SIPA1L2 HECTD1 HSPA5 CAD OFD1 KRT19 CEP192 YWHAE CRYBG3 PCNT | 7.20e-05 | 441 | 237 | 16 | int:KRT8 |
| Interaction | BAP1 interactions | MYCBP2 RPS2 USP9X PABPC4 STK38 MEIOB MCM6 NCL NPM3 S100A11 NCAPD2 SEC16A PEX19 AGFG1 C1QBP MMS19 TAB1 HSPA5 STRN3 CAD PUF60 CALU EFHD2 XPO1 CREBBP YWHAE TIPARP PDIA4 FANCI VPS35 STK38L ATP2A2 | 7.31e-05 | 1314 | 237 | 32 | int:BAP1 |
| Interaction | POLR1E interactions | NCL TTF1 RUNDC3A CHD6 MGA HECTD1 TENT5A CHD8 HEATR1 CREBBP UTP25 VPS35 PAXIP1 MPHOSPH10 | 7.34e-05 | 350 | 237 | 14 | int:POLR1E |
| Interaction | SFN interactions | SETD1A MYCBP2 RPS2 PDPK1 CEP350 PTPN3 MTUS1 TAB1 SIPA1L2 HECTD1 HSPA5 KRT19 CARMIL1 CEP192 YWHAE MST1R PHF3 RAB3IP SSH2 CRYBG3 PALLD | 7.36e-05 | 692 | 237 | 21 | int:SFN |
| Interaction | PTPRN interactions | 7.37e-05 | 117 | 237 | 8 | int:PTPRN | |
| Interaction | RPGRIP1L interactions | VPS33A KIAA0753 CEP350 SIPA1L2 HECTD1 OFD1 CEP192 YWHAE IBTK PCM1 PCNT | 7.61e-05 | 225 | 237 | 11 | int:RPGRIP1L |
| Interaction | SYNE3 interactions | CLGN RPN2 KIAA0753 CEP350 CCDC47 SEC16A PDIA5 TACC1 SIPA1L2 HSPA5 OFD1 CALU CEP192 PDIA4 CRYBG3 PCNT | 7.79e-05 | 444 | 237 | 16 | int:SYNE3 |
| Interaction | RASSF3 interactions | 7.89e-05 | 38 | 237 | 5 | int:RASSF3 | |
| Interaction | CBX3 interactions | SETD1A RTF1 DIAPH2 MGA HSPA5 ZNF280C BAZ1B CHD8 MAU2 HEATR1 XPO1 YWHAE TIPARP SRRT RSBN1 LIG1 RIF1 THOP1 PHF3 CHD5 | 8.37e-05 | 646 | 237 | 20 | int:CBX3 |
| Interaction | STIL interactions | USP9X KIAA0753 CEP350 PIN1 SEC16A SIPA1L2 OFD1 CEP192 PCM1 PCNT | 8.77e-05 | 190 | 237 | 10 | int:STIL |
| Interaction | NIN interactions | VPS33A CEP350 SIPA1L2 MGA HECTD1 OFD1 KRT19 GTSE1 CEP192 CCDC51 YWHAE PALLD PCM1 PCNT | 9.61e-05 | 359 | 237 | 14 | int:NIN |
| Interaction | TRIM29 interactions | FOXN3 PTPN6 SACS SEC16A C1QBP TAB1 HSPA5 CAD SYNE1 XPO1 SRRT | 9.62e-05 | 231 | 237 | 11 | int:TRIM29 |
| Interaction | DOCK3 interactions | 9.64e-05 | 63 | 237 | 6 | int:DOCK3 | |
| Interaction | FAM83A interactions | 1.01e-04 | 40 | 237 | 5 | int:FAM83A | |
| Interaction | EP300 interactions | SETD1A RPN2 USP9X PABPC4 MCM6 EHD4 RTF1 STRN PIN1 C1QBP USP12 PDIA5 MMS19 HECTD1 HSPA5 PUF60 CALU CAPN1 BAZ1B XPO1 PPARG CREBBP TIPARP PDIA4 SRRT RSBN1 RIF1 THRA VPS35 PAXIP1 ATP2A2 PALLD SON | 1.05e-04 | 1401 | 237 | 33 | int:EP300 |
| Interaction | GNL1 interactions | 1.07e-04 | 92 | 237 | 7 | int:GNL1 | |
| Interaction | LCA5 interactions | 1.17e-04 | 125 | 237 | 8 | int:LCA5 | |
| Interaction | SKI interactions | 1.20e-04 | 160 | 237 | 9 | int:SKI | |
| Interaction | TYRO3 interactions | 1.20e-04 | 160 | 237 | 9 | int:TYRO3 | |
| Interaction | MPHOSPH9 interactions | 1.31e-04 | 95 | 237 | 7 | int:MPHOSPH9 | |
| Interaction | SCN2B interactions | 1.31e-04 | 95 | 237 | 7 | int:SCN2B | |
| Interaction | CFAP184 interactions | 1.31e-04 | 162 | 237 | 9 | int:CFAP184 | |
| Interaction | IQCB1 interactions | KNTC1 USP9X ANKAR SEC16A MMS19 HECTD1 HSPA5 STRN3 CAD CALU XPO1 EXOC1 ATP2A2 PCM1 | 1.32e-04 | 370 | 237 | 14 | int:IQCB1 |
| Interaction | UNC93B1 interactions | CLGN RPN2 CCDC47 NCAPD2 PEX19 MMS19 SLC27A2 VIPR1 XPO4 HEATR1 XPO1 FANCI VPS35 EXOC1 ATP2A2 | 1.33e-04 | 417 | 237 | 15 | int:UNC93B1 |
| Interaction | PCNT interactions | SETD1A KIAA0753 CEP350 OFD1 KRT19 SYNE1 CEP192 MADD EXOC1 PCM1 PCNT | 1.40e-04 | 241 | 237 | 11 | int:PCNT |
| Cytoband | 7q35 | 1.03e-05 | 55 | 239 | 5 | 7q35 | |
| GeneFamily | CTAGE family | 1.30e-07 | 15 | 157 | 5 | 907 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 6.42e-07 | 3 | 157 | 3 | 287 | |
| GeneFamily | ATPases Ca2+ transporting | 5.19e-05 | 9 | 157 | 3 | 1209 | |
| GeneFamily | EF-hand domain containing | 6.65e-04 | 219 | 157 | 8 | 863 | |
| GeneFamily | Ankyrin repeat domain containing|Death associated protein kinases | 7.37e-04 | 5 | 157 | 2 | 1021 | |
| GeneFamily | Exportins | 1.53e-03 | 7 | 157 | 2 | 547 | |
| GeneFamily | CD molecules|Integrin beta subunits | 2.59e-03 | 9 | 157 | 2 | 1159 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 2.59e-03 | 9 | 157 | 2 | 1203 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | KNTC1 KIF18A MYCBP2 USP9X NCL RPS6KC1 KIAA0319 CEP350 MTUS1 SACS CCDC47 USP12 HECTD1 TENT5A BAZ1B CEP192 XPO1 RIF1 PHF3 EXOC1 MPHOSPH10 DAAM1 PALLD PCM1 SON | 1.95e-09 | 656 | 239 | 25 | M18979 |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | KNTC1 KIF18A RPN2 PABPC4 MCM6 NCL NPM3 CCDC47 NCAPD2 AGFG1 C1QBP MMS19 CAD KRT19 PUF60 CALU GTSE1 HEATR1 ODC1 PDIA4 LIG1 FANCI PAXIP1 PCM1 | 2.40e-09 | 612 | 239 | 24 | M4772 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | EPHB2 KDM5B MYCBP2 USP9X RABGAP1 FOXN3 CEP350 SACS AGFG1 USP12 STRN3 BAZ1B XPO1 STAM CREBBP TIPARP RSBN1 IBTK RIF1 PHF3 RBM6 ZFHX3 CRYBG3 DAAM1 ATP2B4 SON PCNT | 2.34e-08 | 856 | 239 | 27 | M4500 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | CEP350 PTPN3 STRN MTUS1 SACS BAZ1B XPO1 CREBBP TIPARP RSBN1 RIF1 MLH3 PHF3 MPHOSPH10 | 7.55e-07 | 300 | 239 | 14 | M8702 |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | KNTC1 USP9X CEP350 NF1 ATP8A1 NCAPD2 BAZ1B CREBBP RIF1 ATP2A2 PCM1 | 8.78e-07 | 180 | 239 | 11 | M8239 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | EPHB2 HSPA12A SBF1 PMPCA SEC16A SLC27A2 IFT27 CAD CAPN1 PDIA4 LIG1 THRA ATP2A2 | 1.70e-06 | 276 | 239 | 13 | M3063 |
| Coexpression | PUJANA_CHEK2_PCC_NETWORK | KNTC1 MCM6 NCL TTF1 NPM3 NF1 PMPCA NCAPD2 C1QBP TAF5 CAD GTSE1 BAZ1B ODC1 XPO1 YWHAE LIG1 RIF1 THOP1 FANCI PAXIP1 MPHOSPH10 | 2.11e-06 | 761 | 239 | 22 | M11961 |
| Coexpression | GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP | EPHB2 KDM5B MYCBP2 STK38 CHST12 SYNE1 XPO1 JMJD1C MYO1F ATP2B4 PCM1 | 2.13e-06 | 197 | 239 | 11 | M3136 |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | KNTC1 RABGAP1 NF1 NCK2 CEP192 YWHAE SSH2 STK38L PALLD PCM1 PCNT | 2.35e-06 | 199 | 239 | 11 | M5893 |
| Coexpression | GSE3039_ALPHAALPHA_CD8_TCELL_VS_B2_BCELL_UP | CNBD2 PTPN6 ZFAT CAPN1 PPARG PDIA4 ELMO2 PABPC1L ICA1L MINDY1 SON | 2.46e-06 | 200 | 239 | 11 | M6437 |
| Coexpression | GABRIELY_MIR21_TARGETS | MYCBP2 RABGAP1 FOXN3 RTF1 PTPN3 TACC1 MGA HECTD1 TENT5A NBEA FANCI ATP2B4 PALLD | 2.83e-06 | 289 | 239 | 13 | M2196 |
| Coexpression | DEN_INTERACT_WITH_LCA5 | 3.40e-06 | 26 | 239 | 5 | M1380 | |
| Coexpression | LEE_BMP2_TARGETS_DN | EPHB2 TFDP3 MCM6 COL22A1 NLN PMPCA SACS PIN1 AGFG1 C1QBP TAF5 HSPA5 CAD XPO4 CEP192 HEATR1 ODC1 XPO1 RIF1 THOP1 UTP25 PAXIP1 MPHOSPH10 | 1.37e-05 | 922 | 239 | 23 | MM1068 |
| Coexpression | GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_DN | MYCBP2 RABGAP1 ATP8A1 IQSEC1 CARD6 USP12 HEATR1 JMJD1C CAMKMT SSH2 | 1.56e-05 | 199 | 239 | 10 | M9253 |
| Coexpression | GSE360_L_DONOVANI_VS_M_TUBERCULOSIS_MAC_UP | FOXN3 S100A11 USP12 TAB1 MERTK MGA HSPA5 DNAH7 PDIA4 MPHOSPH10 | 1.63e-05 | 200 | 239 | 10 | M5241 |
| Coexpression | GSE7460_CTRL_VS_TGFB_TREATED_ACT_FOXP3_MUT_TCONV_DN | DAPK2 STRA8 ISM1 ANKRD34B MTUS1 DIAPH2 AGFG1 APEH STK38L EPHA8 | 1.63e-05 | 200 | 239 | 10 | M5699 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | USP9X TTF1 RYR3 CEP350 SACS CCDC47 SCN9A IQSEC1 C1QBP PDIA5 TACC1 HSPA5 NCK2 R3HCC1 KRBOX4 ODC1 XPO1 YWHAE IBTK IFT52 UTP25 ELMO2 FANCI PAXIP1 DAAM1 ATP2A2 PCM1 | 1.90e-05 | 1215 | 239 | 27 | M41122 |
| Coexpression | PUJANA_XPRSS_INT_NETWORK | 2.52e-05 | 168 | 239 | 9 | M18811 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | SYCP2L MYCBP2 FAM114A2 FOXN3 CSMD2 CSMD3 RYR2 EHD4 NLN HSPA12A RUNDC3A ATP8A1 MTUS1 ANKAR SCN3A SCN9A NBEA THRA CHD5 ZFHX3 SSH2 DAAM1 ATP2B2 ICA1L ARMH4 | 2.99e-05 | 1106 | 239 | 25 | M39071 |
| Coexpression | LEE_BMP2_TARGETS_DN | EPHB2 MCM6 COL22A1 NLN PMPCA SACS PIN1 AGFG1 C1QBP TAF5 HSPA5 CAD XPO4 CEP192 HEATR1 ODC1 XPO1 RIF1 THOP1 UTP25 PAXIP1 MPHOSPH10 | 3.09e-05 | 904 | 239 | 22 | M2325 |
| Coexpression | GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN | 3.10e-05 | 66 | 239 | 6 | M12812 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | EPHB2 KNTC1 KIF18A RPN2 MCM6 NCL COL22A1 ITGB6 CD163 NLN NF1 SACS C1QBP TAF5 CAD CALU ZNF280C BAZ1B B3GALT6 CEP192 HEATR1 XPO1 POSTN RIF1 FBH1 UTP25 FANCI PAXIP1 ZNF84 | 3.65e-05 | 1407 | 239 | 29 | M14427 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | USP9X WIPF3 EHD4 STRN HSPA12A MTUS1 DIAPH2 IQSEC1 AGFG1 USP12 TACC1 MERTK FAM135A NCK2 TENT5A CREBBP TIPARP PPP4R3B ZBTB46 PALLD SON | 4.06e-05 | 854 | 239 | 21 | M1533 |
| Coexpression | BAELDE_DIABETIC_NEPHROPATHY_DN | RPN2 USP9X MCM6 HSPA12A PTPRD HSPA5 CALU ODC1 XPO1 YWHAE POSTN RSBN1 ATP2A2 PALLD | 5.37e-05 | 437 | 239 | 14 | M4665 |
| Coexpression | PGF_UP.V1_UP | 6.59e-05 | 190 | 239 | 9 | M2674 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | USP9X WIPF3 EHD4 STRN HSPA12A MTUS1 DIAPH2 IQSEC1 AGFG1 USP12 TACC1 MERTK FAM135A NCK2 TENT5A CREBBP TIPARP PPP4R3B ZBTB46 PALLD SON | 7.07e-05 | 888 | 239 | 21 | MM1018 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | KDM5B RABGAP1 RPS6KC1 MTUS1 MAU2 STAM PPARG NR1D1 CREBBP JMJD1C TIPARP IBTK FICD UTP25 PHF3 ZNF84 DAAM1 TOPORS ATP2B4 PALLD | 7.19e-05 | 822 | 239 | 20 | M6782 |
| Coexpression | GSE42021_TREG_PLN_VS_TREG_PRECURSORS_THYMUS_UP | 8.69e-05 | 197 | 239 | 9 | M9569 | |
| Coexpression | GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_DN | 8.69e-05 | 197 | 239 | 9 | M7683 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | KNTC1 KIF18A MCM6 NCL PTPN6 NCAPD2 TAF5 GTSE1 CEP192 ODC1 XPO1 LIG1 RIF1 UTP25 FANCI PALLD | 8.96e-05 | 578 | 239 | 16 | M2368 |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_MAC_UP | 9.39e-05 | 199 | 239 | 9 | M5235 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | KNTC1 KIF18A MCM6 NPM3 NLN AGFG1 CPSF2 CALU GTSE1 HEATR1 STAM PPP4R3B RIF1 FANCI VPS35 CD58 MPHOSPH10 | 9.62e-05 | 644 | 239 | 17 | M10501 |
| Coexpression | GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_NONATOPIC_PATIENT_UP | 9.76e-05 | 200 | 239 | 9 | M7086 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_UP | 9.76e-05 | 200 | 239 | 9 | M9944 | |
| Coexpression | GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN | 9.76e-05 | 200 | 239 | 9 | M7150 | |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_RAG2_KO_NK_CELL_DN | 9.76e-05 | 200 | 239 | 9 | M8851 | |
| Coexpression | GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP | 9.76e-05 | 200 | 239 | 9 | M6477 | |
| Coexpression | GSE21927_BALBC_VS_C57BL6_MONOCYTE_TUMOR_UP | 9.76e-05 | 200 | 239 | 9 | M7606 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | MYCBP2 RPS2 USP9X SPEF2 CEP350 PTPN6 ATP8A1 SACS AGFG1 CHST12 TACC1 OFD1 SYNE1 BAZ1B XPO4 OAZ1 ODC1 XPO1 CREBBP JMJD1C PPP4R3B RIF1 ELMO2 PHF3 MYO1F SSH2 ATP2B4 PCM1 SON | 1.03e-04 | 1492 | 239 | 29 | M40023 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | MYCBP2 USP9X RABGAP1 FOXN3 CEP350 USP12 STRN3 XPO1 STAM CREBBP TIPARP IBTK PHF3 RBM6 | 1.06e-04 | 466 | 239 | 14 | M13522 |
| Coexpression | CHEN_LUNG_CANCER_SURVIVAL | 1.16e-04 | 28 | 239 | 4 | M8526 | |
| Coexpression | IBRAHIM_NRF2_UP | NCL RPS6KC1 NLN CCDC47 PEX19 AGFG1 TAF5 MERTK HSPA5 STRN3 CALU ODC1 PPP4R3B MLH3 VPS35 | 1.24e-04 | 533 | 239 | 15 | M42510 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | KNTC1 KIF18A MCM6 NCL PTPN6 NCAPD2 TAF5 GTSE1 CEP192 ODC1 XPO1 LIG1 RIF1 UTP25 FANCI PALLD | 1.30e-04 | 597 | 239 | 16 | MM1309 |
| Coexpression | PUJANA_BRCA2_PCC_NETWORK | KNTC1 CLGN MCM6 TTF1 NCAPD2 CAD GTSE1 XPO1 LIG1 RIF1 FANCI PAXIP1 ZNF84 | 1.60e-04 | 426 | 239 | 13 | M9516 |
| Coexpression | ZAMORA_NOS2_TARGETS_UP | 1.72e-04 | 57 | 239 | 5 | M1507 | |
| Coexpression | GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP | 1.82e-04 | 171 | 239 | 8 | M2947 | |
| Coexpression | GSE32901_NAIVE_VS_TH17_NEG_CD4_TCELL_UP | 1.90e-04 | 172 | 239 | 8 | M8932 | |
| Coexpression | MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN | MYCBP2 RABGAP1 NLRC4 SACS SEC16A USP12 SYNE1 YWHAE JMJD1C SON | 2.12e-04 | 272 | 239 | 10 | M15123 |
| Coexpression | ZAMORA_NOS2_TARGETS_UP | 2.19e-04 | 60 | 239 | 5 | MM1165 | |
| Coexpression | LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS | 2.31e-04 | 177 | 239 | 8 | M39245 | |
| Coexpression | DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN | KDM5B DAPK3 DTX3L ITGB6 RPS6KC1 ATP8A1 DIAPH2 TACC1 OFD1 NBEA PPARG ATP6V0A4 STK38L PALLD | 2.38e-04 | 504 | 239 | 14 | M2157 |
| Coexpression | GSE13522_WT_VS_IFNAR_KO_SKIN_DN | 2.40e-04 | 178 | 239 | 8 | M2925 | |
| Coexpression | GCNP_SHH_UP_LATE.V1_UP | 2.68e-04 | 181 | 239 | 8 | M2641 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL | KIF18A CLGN VPS33A MCM6 COL22A1 CNBD2 ITGB4 STRN HSPA12A PTPRD NCAPD2 CAB39L DCLRE1A TAF5 SIPA1L2 COL28A1 GTSE1 CEP192 LIG1 CD58 CRYBG3 TRIM47 | 2.80e-04 | 1054 | 239 | 22 | M45798 |
| Coexpression | EPPERT_PROGENITOR | 2.83e-04 | 138 | 239 | 7 | M19232 | |
| Coexpression | GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP | 3.00e-04 | 184 | 239 | 8 | M9005 | |
| Coexpression | DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_IMMATURE_NEURONS | 3.08e-04 | 140 | 239 | 7 | M39288 | |
| Coexpression | BUSSLINGER_GASTRIC_ISTHMUS_CELLS | RPN2 NCL ITGB4 S100A11 HSPA5 KRT19 TENT5A EFHD2 PPARG PDIA4 IBTK VPS35 PALLD | 3.23e-04 | 458 | 239 | 13 | M40010 |
| Coexpression | KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP | KNTC1 KIF18A CLGN RPS2 MEIOB MCM6 TTF1 NCAPD2 C1QBP TACC1 CPSF2 TAF5 GTSE1 ZNF280C CA13 XPO4 YWHAE LIG1 RIF1 THOP1 LOXHD1 FANCI RAB3IP FBXO43 ATP2A2 | 3.30e-04 | 1290 | 239 | 25 | M80 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA1 | CSMD2 CSMD3 PTPN3 NLN HSPA12A RUNDC3A SCN3A SCN9A NBEA ZBTB46 CHD5 ZFHX3 SSH2 DAAM1 ARMH4 | 3.31e-04 | 584 | 239 | 15 | M39068 |
| Coexpression | BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING | 3.46e-04 | 237 | 239 | 9 | M7068 | |
| Coexpression | GSE37605_C57BL6_VS_NOD_FOXP3_IRES_GFP_TCONV_UP | 3.51e-04 | 143 | 239 | 7 | M8819 | |
| Coexpression | MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN | 3.68e-04 | 67 | 239 | 5 | M9325 | |
| Coexpression | GSE45365_NK_CELL_VS_CD8_TCELL_DN | 3.85e-04 | 191 | 239 | 8 | M10008 | |
| Coexpression | PUJANA_ATM_PCC_NETWORK | KNTC1 SETD1A DAPK2 STK38 MCM6 NCL NPM3 STRN PTPN6 NCAPD2 FSCN2 C1QBP TAB1 TAF5 CAD OFD1 GTSE1 BAZ1B ODC1 XPO1 RIF1 THRA PHF3 FANCI PAXIP1 RBM6 | 4.47e-04 | 1394 | 239 | 26 | M9585 |
| Coexpression | MCMURRAY_TP53_HRAS_COOPERATION_RESPONSE_DN | 4.52e-04 | 70 | 239 | 5 | MM809 | |
| Coexpression | GSE9960_HEALTHY_VS_GRAM_NEG_AND_POS_SEPSIS_PBMC_DN | 4.57e-04 | 196 | 239 | 8 | M7124 | |
| Coexpression | GSE12845_IGD_POS_VS_NEG_BLOOD_BCELL_DN | 4.57e-04 | 196 | 239 | 8 | M3183 | |
| Coexpression | MATTIOLI_MULTIPLE_MYELOMA_SUBGROUPS | 4.63e-04 | 17 | 239 | 3 | M15055 | |
| Coexpression | GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_UP | 4.73e-04 | 197 | 239 | 8 | M7682 | |
| Coexpression | GSE19198_6H_VS_24H_IL21_TREATED_TCELL_DN | 4.89e-04 | 198 | 239 | 8 | M7228 | |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_6H_DN | 4.89e-04 | 198 | 239 | 8 | M6104 | |
| Coexpression | GSE12366_GC_VS_MEMORY_BCELL_UP | 4.89e-04 | 198 | 239 | 8 | M3171 | |
| Coexpression | GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_DN | 5.06e-04 | 199 | 239 | 8 | M9422 | |
| Coexpression | GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_NK_CELL_UP | 5.06e-04 | 199 | 239 | 8 | M9410 | |
| Coexpression | GSE14308_NAIVE_CD4_TCELL_VS_INDUCED_TREG_UP | 5.06e-04 | 199 | 239 | 8 | M3391 | |
| Coexpression | GSE22025_PROGESTERONE_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_UP | 5.06e-04 | 199 | 239 | 8 | M8381 | |
| Coexpression | GSE42021_CD24HI_VS_CD24LOW_TREG_THYMUS_UP | 5.06e-04 | 199 | 239 | 8 | M9587 | |
| Coexpression | GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN | 5.06e-04 | 199 | 239 | 8 | M6030 | |
| Coexpression | GSE31082_DP_VS_CD4_SP_THYMOCYTE_DN | 5.06e-04 | 199 | 239 | 8 | M5065 | |
| Coexpression | GSE360_DC_VS_MAC_L_MAJOR_DN | 5.06e-04 | 199 | 239 | 8 | M5182 | |
| Coexpression | GSE11057_NAIVE_VS_CENT_MEMORY_CD4_TCELL_DN | 5.06e-04 | 199 | 239 | 8 | M3107 | |
| Coexpression | GSE24634_TEFF_VS_TCONV_DAY7_IN_CULTURE_UP | 5.23e-04 | 200 | 239 | 8 | M4622 | |
| Coexpression | GSE411_WT_VS_SOCS3_KO_MACROPHAGE_DN | 5.23e-04 | 200 | 239 | 8 | M5991 | |
| Coexpression | GSE24634_TREG_VS_TCONV_POST_DAY3_IL4_CONVERSION_UP | 5.23e-04 | 200 | 239 | 8 | M4599 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN | 5.23e-04 | 200 | 239 | 8 | M5851 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_DN | 5.23e-04 | 200 | 239 | 8 | M9923 | |
| Coexpression | GSE27859_DC_VS_CD11C_INT_F480_INT_DC_DN | 5.23e-04 | 200 | 239 | 8 | M8600 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_16H_BMDC_DN | 5.23e-04 | 200 | 239 | 8 | M3978 | |
| Coexpression | GSE3039_CD4_TCELL_VS_B2_BCELL_UP | 5.23e-04 | 200 | 239 | 8 | M6462 | |
| Coexpression | GSE360_DC_VS_MAC_B_MALAYI_LOW_DOSE_DN | 5.23e-04 | 200 | 239 | 8 | M5188 | |
| Coexpression | HALLMARK_MYC_TARGETS_V1 | 5.23e-04 | 200 | 239 | 8 | M5926 | |
| Coexpression | GSE360_L_DONOVANI_VS_L_MAJOR_MAC_UP | 5.23e-04 | 200 | 239 | 8 | M5231 | |
| Coexpression | GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_DN | 5.23e-04 | 200 | 239 | 8 | M9037 | |
| Coexpression | GSE39110_DAY3_VS_DAY6_POST_IMMUNIZATION_CD8_TCELL_UP | 5.23e-04 | 200 | 239 | 8 | M9276 | |
| Coexpression | GSE40666_WT_VS_STAT4_KO_CD8_TCELL_WITH_IFNA_STIM_90MIN_UP | 5.23e-04 | 200 | 239 | 8 | M9216 | |
| Coexpression | GSE11924_TFH_VS_TH17_CD4_TCELL_DN | 5.23e-04 | 200 | 239 | 8 | M3157 | |
| Coexpression | GSE9239_CTRL_VS_TNF_INHIBITOR_TREATED_DC_DN | 5.23e-04 | 200 | 239 | 8 | M6966 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN | TFDP3 FOXN3 PTPRD SIPA1L2 CTAGE9 STRN3 KRT19 CREBBP YWHAE PDIA4 CTAGE8 ZFHX3 PALLD | 5.42e-04 | 484 | 239 | 13 | MM999 |
| Coexpression | WIERENGA_PML_INTERACTOME | 5.75e-04 | 42 | 239 | 4 | M2219 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500 | KNTC1 KIF18A GLT1D1 STRA8 MEIOB PTPN3 PTPN6 TAF5 SLC27A2 CAD OFD1 CEP192 HEATR1 RIF1 FANCI STK38L | 1.51e-05 | 406 | 238 | 16 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#2_top-relative-expression-ranked_1000 | MYCBP2 USP9X VPS33A RABGAP1 DTX3L RYR2 CEP350 TENT5A BAZ1B CREBBP RSBN1 IBTK RIF1 PHF3 | 2.32e-05 | 330 | 238 | 14 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k2_1000 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.33e-09 | 195 | 239 | 11 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.33e-09 | 195 | 239 | 11 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-08 | 169 | 239 | 10 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GLT1D1 RYR1 OTOF SCN3A USP12 ZBTB46 RAB3IP PLEKHM3 DAAM1 PALLD | 3.34e-08 | 172 | 239 | 10 | 2a4614b3d25e8c6b095e6992d8ca35371dcdb5e1 |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GLT1D1 RYR1 OTOF SCN3A USP12 ZBTB46 RAB3IP PLEKHM3 DAAM1 PALLD | 3.34e-08 | 172 | 239 | 10 | 7fb31ccbcd0204c3612986a6bc20d57ed6825e9c |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.89e-08 | 193 | 239 | 10 | 471e65f02937bc18d7c5facdacdf1df58cf0f839 | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.89e-08 | 193 | 239 | 10 | fe451b3295d77b2bd1ac25cf29310c85835a45fe | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c13-MKI67-CCL5_l|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.25e-07 | 150 | 239 | 9 | 6f7087a051a2f05c5611ff65a945c01736d5ec2b | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.35e-07 | 178 | 239 | 9 | 0e1bedf991189d0ef9b40dac9281bdf4739333a1 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | RABGAP1 ITGB4 PDIA5 FAM135A ZMYND15 CALU SYT15 TRIM47 ATP2B4 | 6.75e-07 | 183 | 239 | 9 | 12e876d6205af8aad74265c668b5e95b9e7487f3 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-07 | 184 | 239 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-07 | 184 | 239 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.07e-07 | 184 | 239 | 9 | 157a3d00165bb4a8c52c3e63ae57d9cf57500be7 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.07e-07 | 184 | 239 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D175|Adult / Lineage, Cell type, age group and donor | 7.39e-07 | 185 | 239 | 9 | ab5704b96f1d368911308797d10c7c52766ab134 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.39e-07 | 185 | 239 | 9 | 929b68b05b7686341329ac756d7df172cb4b810b | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.09e-07 | 187 | 239 | 9 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.09e-07 | 187 | 239 | 9 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.65e-07 | 191 | 239 | 9 | 6e1d00404d795ec7cf60f685e42e4ad9a16ac596 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 9.65e-07 | 191 | 239 | 9 | f158e393976b685b896a41871bda1ab65a8b58f5 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-06 | 192 | 239 | 9 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | droplet-Pancreas-Endocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 194 | 239 | 9 | 3a3ecedcdc7691cf21775818b598208fcb980c29 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-06 | 194 | 239 | 9 | 4579b4a44f7c731553a284843c296866027d7c0e | |
| ToppCell | droplet-Pancreas-Endocrine-21m-Epithelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 194 | 239 | 9 | 0b023de48ed8a550d169bbe954881eb04bf4f981 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.15e-06 | 195 | 239 | 9 | 3d6d3de8ada6dce3dc789c15b50cc066e7100496 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 1.20e-06 | 196 | 239 | 9 | 36ed1918f70b6f5760bb088b15ce422998055cc7 | |
| ToppCell | Sepsis-Bac-SEP-Myeloid-tDC|Bac-SEP / Disease, condition lineage and cell class | 1.36e-06 | 199 | 239 | 9 | a2be40d367338d32348a6906c8475aa3b544a0f7 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.41e-06 | 200 | 239 | 9 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.41e-06 | 200 | 239 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | Sigmoid-B_cell-B_cell_IgA_Plasma|B_cell / Region, Cell class and subclass | 1.41e-06 | 200 | 239 | 9 | 5af830c85305db3db5ebd6cedc9c1a96b67ce126 | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.41e-06 | 200 | 239 | 9 | e4eb915c29909cf8535a3603c68976545c05e54b | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.41e-06 | 200 | 239 | 9 | 415e7556b5ac45688e2c6c30a52bd40e0eb27c7d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 2.89e-06 | 163 | 239 | 8 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | Bac-SEP-Myeloid-tDC|Bac-SEP / Disease, Lineage and Cell Type | 3.16e-06 | 165 | 239 | 8 | 8728f927502e56f2768b4224e9111939d3d7815a | |
| ToppCell | droplet-Kidney-nan-24m-Myeloid-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-06 | 167 | 239 | 8 | 2ee1660be117e20f24557522345572d11cbee813 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.61e-06 | 168 | 239 | 8 | 4b5be7c6662eceddf90a65015f12908278d1664e | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.61e-06 | 168 | 239 | 8 | 689c41f6e9f65381570991cc311cba49a57ec955 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-06 | 169 | 239 | 8 | ba023ee7bb165c2bfbefc2d969ff32ca1eeed33b | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-06 | 169 | 239 | 8 | c96e0f3241d13926dbee9f91c0c8c5bfa7479a0d | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.09e-06 | 176 | 239 | 8 | 24b2e94ee5defcefb64a1f2447a2cc71b015b0fd | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2-AT2_Progenitor|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.26e-06 | 181 | 239 | 8 | 0513b9e6673ff7bf8e72ba123ca3794b65d10170 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.51e-06 | 182 | 239 | 8 | 17ed11a7ea366dd3106400511d5e628d3f1a9c3e | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 6.78e-06 | 183 | 239 | 8 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_2|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.78e-06 | 183 | 239 | 8 | e972432dd4d1bd31bb0982f4df3061e5e152658f | |
| ToppCell | Control-Epithelial_alveolar-AT_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.06e-06 | 184 | 239 | 8 | 51e129b3fcc2df083eda05a3afe3717218b1e52b | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.34e-06 | 185 | 239 | 8 | fefaf227d89f680d6f3e91c4a94e26ab4d0dc6c3 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 7.34e-06 | 185 | 239 | 8 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.34e-06 | 185 | 239 | 8 | eb7d3c1363d5fedc611f9c1a91ea823de251355e | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 8.26e-06 | 188 | 239 | 8 | e751cff2ac8fbc1487766c1871fcc5d1005286b0 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_3|COVID-19_Convalescent / Disease condition and Cell class | 8.58e-06 | 189 | 239 | 8 | 732e8dcffcb634ca2968f9170c9c4b31dd5d4206 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.92e-06 | 190 | 239 | 8 | 3fc9e18c7441c0ae8cda65753cc42d0520f4e116 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 9.27e-06 | 191 | 239 | 8 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.63e-06 | 192 | 239 | 8 | f7e7491426bbd6ed29a465b58bf67acb93dbb90a | |
| ToppCell | COVID-19-kidney-CNT|kidney / Disease (COVID-19 only), tissue and cell type | 9.63e-06 | 192 | 239 | 8 | d32ae226d95b4b6adb99d14b602be09b661d4cd9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 193 | 239 | 8 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 193 | 239 | 8 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.00e-05 | 193 | 239 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.00e-05 | 193 | 239 | 8 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.04e-05 | 194 | 239 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | B_cells-Plasma_cells_and_plasmablasts|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.16e-05 | 197 | 239 | 8 | 3b1c574b3d119b63967bb1306f0353ecc4c522f3 | |
| ToppCell | facs-Trachea-nan-3m|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-05 | 197 | 239 | 8 | 0353d925ee4b7aefc2c51b5fab873f465cdf9ebc | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 197 | 239 | 8 | 91637bdeab85024b5a02d1066f76cb803a2d6420 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 197 | 239 | 8 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 197 | 239 | 8 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.16e-05 | 197 | 239 | 8 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.16e-05 | 197 | 239 | 8 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Monocytes-Macrophages|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.18e-05 | 142 | 239 | 7 | b66f9602dba30d1d4fbcc49ceb112eb5bd916ba1 | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 1.20e-05 | 198 | 239 | 8 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.20e-05 | 198 | 239 | 8 | d12f37527399038a8f030b45b176bda5c7c8a7ad | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-05 | 198 | 239 | 8 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.25e-05 | 199 | 239 | 8 | b10698aee2e6c17bc559eb4f723024141f914b90 | |
| ToppCell | TCGA-Stomach-Primary_Tumor|TCGA-Stomach / Sample_Type by Project: Shred V9 | 1.25e-05 | 199 | 239 | 8 | 38f1f612b29feb868322999ceeda78e52447ec4f | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.25e-05 | 199 | 239 | 8 | 3cd6383c50ce342fe5c175e2e50784d634a90e80 | |
| ToppCell | Control-Control-Myeloid-immature_Neutrophil|Control / Disease, condition lineage and cell class | 1.29e-05 | 200 | 239 | 8 | 118321ac443feb42aee171baccfc4610f00a8822 | |
| ToppCell | Transverse-B_cell-B_cell_IgA_Plasma|B_cell / Region, Cell class and subclass | 1.29e-05 | 200 | 239 | 8 | 210c4a9221cf5c035c4e6c01755d17fe3b80a3fe | |
| ToppCell | Control_saline-Endothelial-Endothelial-Artery|Control_saline / Treatment groups by lineage, cell group, cell type | 1.29e-05 | 200 | 239 | 8 | 65b71f1e8da5c3750fcd0a2e66d9ef3125a3f78a | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Artery|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.29e-05 | 200 | 239 | 8 | b1ff8d61b567f85006d6d20093f9c803b6d34674 | |
| ToppCell | mild-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.29e-05 | 200 | 239 | 8 | 63cc57b9331459efbb73051d174d198a3568b938 | |
| ToppCell | LPS-IL1RA-Endothelial-Mes-Like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.35e-05 | 145 | 239 | 7 | 90ca38c02325c5c637c32efdef634b54cc3cd105 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-05 | 145 | 239 | 7 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 147 | 239 | 7 | 989a48bda98fbff398985397a6b1189a4cbc80e7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-05 | 147 | 239 | 7 | f6681c849c4c06154548bd29a094f202d1c946c2 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.09e-05 | 155 | 239 | 7 | 4559e3011514041b65c17ae4ede29da202bce14c | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 2.09e-05 | 155 | 239 | 7 | 9d53caee196b5c2bbc90c4f54f693b64d4086065 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.17e-05 | 156 | 239 | 7 | af47a4b17342bdb3cb62d7e2d52a81168e588629 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.46e-05 | 159 | 239 | 7 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-05 | 160 | 239 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.56e-05 | 160 | 239 | 7 | 8bb873704895c3b35bba8af78fedbabf7df42e71 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-05 | 160 | 239 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.77e-05 | 162 | 239 | 7 | 7d43d59531cbefe3ac94953b7faf7156b2a31441 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.88e-05 | 163 | 239 | 7 | bbbc3f0ce2616d07136f69ce682ba1d3790711d9 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.00e-05 | 164 | 239 | 7 | 11dfd84f5fb90de330858e1e852848832734e004 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.00e-05 | 164 | 239 | 7 | 519ab4fe885dfe4c50846f346a062acc2cb44299 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.36e-05 | 167 | 239 | 7 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.63e-05 | 169 | 239 | 7 | 305cedbd97059029d7d2a248a8a4b6cfe281aa54 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-5_RORB_HSPB3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.77e-05 | 170 | 239 | 7 | 985c6c9e3c593ed0628a481f06c2c91b2ab5d746 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.77e-05 | 170 | 239 | 7 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Rorb|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.85e-05 | 116 | 239 | 6 | 9c92e714e210a2f29a9e228653d4c990ec643c72 | |
| ToppCell | E16.5-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal-Deuterosomal_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.91e-05 | 171 | 239 | 7 | 4f2a83d8091f1fd29542d2e5add57fd482e921b5 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Classical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-05 | 173 | 239 | 7 | 3c51e7bda1835c25915e50c801b0d643979971a3 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | KDM5B TTF1 CEP350 PTPN3 TAF5 MGA CREBBP JMJD1C TIPARP RSBN1 RIF1 MLH3 UTP25 PHF3 | 8.79e-09 | 184 | 237 | 14 | 2321_DN |
| Drug | strontium | 5.29e-07 | 68 | 237 | 8 | CID000104798 | |
| Drug | cis-diammineplatinum(II | 1.11e-06 | 3 | 237 | 3 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 1.11e-06 | 3 | 237 | 3 | CID002750949 | |
| Drug | 8N3-cADPR | 1.11e-06 | 3 | 237 | 3 | CID000127713 | |
| Drug | aminodantrolene | 1.11e-06 | 3 | 237 | 3 | CID009570289 | |
| Drug | 2-hydroxycarbazole | 1.11e-06 | 3 | 237 | 3 | CID000093551 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 1.11e-06 | 3 | 237 | 3 | CID005748312 | |
| Drug | Aztreonam [78110-38-0]; Down 200; 9.2uM; HL60; HG-U133A | RPS2 TACC1 HSD17B4 SLC27A2 STRN3 TENT5A STAM SRBD1 IBTK UTP25 STK38L ATP2B4 | 1.20e-06 | 198 | 237 | 12 | 1435_DN |
| Drug | mag-fura-2 | 2.12e-06 | 37 | 237 | 6 | CID000123839 | |
| Drug | XeC compound | 2.70e-06 | 84 | 237 | 8 | CID000005701 | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | KIF18A KDM5B CEP350 TAF5 STRN3 CREBBP JMJD1C TIPARP RSBN1 UTP25 PHF3 | 3.11e-06 | 180 | 237 | 11 | 4541_DN |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | KDM5B CEP350 TAF5 MGA STRN3 STAM CREBBP RIF1 UTP25 ZNF84 SON | 3.46e-06 | 182 | 237 | 11 | 3887_DN |
| Drug | R 478 | 3.57e-06 | 11 | 237 | 4 | CID000084223 | |
| Drug | PCB74 | 4.42e-06 | 4 | 237 | 3 | CID000036218 | |
| Drug | 148504-47-6 | 4.42e-06 | 4 | 237 | 3 | CID006444275 | |
| Drug | SC 38249 | 4.42e-06 | 4 | 237 | 3 | CID000134834 | |
| Drug | AC1L1U7A | 4.42e-06 | 4 | 237 | 3 | CID000035682 | |
| Drug | fluo-3 | 5.42e-06 | 122 | 237 | 9 | CID000104978 | |
| Drug | p-nitrophenyl phosphate | ACP6 PTPN3 PTPN6 PTPRD MMS19 TAB1 POSTN SSH2 ATP2A2 ATP2B2 ATP2B4 | 6.38e-06 | 194 | 237 | 11 | CID000000378 |
| Drug | Fendiline hydrochloride [13636-18-5]; Down 200; 11.4uM; MCF7; HT_HG-U133A | EPHB2 VPS33A FAM114A2 SBF1 SACS IQSEC1 DCLRE1A BAZ1B THOP1 ATP2B4 MINDY1 | 6.70e-06 | 195 | 237 | 11 | 7188_DN |
| Drug | bepridil | 7.06e-06 | 126 | 237 | 9 | CID000002351 | |
| Drug | tBuBHQ | 7.55e-06 | 69 | 237 | 7 | CID000002374 | |
| Drug | dithiotreitol | DAPK2 DAPK3 RYR1 RYR2 RYR3 SCTR HSPA5 VIPR1 ODC1 TIPARP ACOT12 POSTN THOP1 ATP2A2 ATP2B2 ATP2B4 | 1.25e-05 | 430 | 237 | 16 | CID000019001 |
| Drug | chloro-m-cresol | 2.18e-05 | 6 | 237 | 3 | CID000012008 | |
| Drug | MBED | 2.18e-05 | 6 | 237 | 3 | CID000129958 | |
| Drug | AC1O528X | 2.18e-05 | 6 | 237 | 3 | CID006475857 | |
| Drug | NSC114784 | 2.18e-05 | 6 | 237 | 3 | CID000419425 | |
| Drug | Doxorubicin hydrochloride [25316-40-9]; Down 200; 6.8uM; MCF7; HT_HG-U133A | KIF18A CEP350 TAF5 MGA JMJD1C TIPARP RIF1 PHF3 ZNF84 MPHOSPH10 | 2.92e-05 | 188 | 237 | 10 | 3291_DN |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 3.78e-05 | 7 | 237 | 3 | CID009547999 | |
| Drug | Azumoleno | 3.78e-05 | 7 | 237 | 3 | CID000056259 | |
| Drug | Br2BAPTA | 3.78e-05 | 7 | 237 | 3 | CID003081001 | |
| Drug | Felodipine [72509-76-3]; Down 200; 10.4uM; PC3; HT_HG-U133A | 3.82e-05 | 194 | 237 | 10 | 6695_DN | |
| Drug | AC1L380G | 3.92e-05 | 19 | 237 | 4 | CID000084698 | |
| Drug | Dipyrone [5907-38-0]; Down 200; 12uM; MCF7; HT_HG-U133A | 3.99e-05 | 195 | 237 | 10 | 3835_DN | |
| Drug | carbamazepine; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA | 3.99e-05 | 195 | 237 | 10 | 919_UP | |
| Drug | Metronidazole [443-48-1]; Down 200; 23.4uM; PC3; HG-U133A | 4.17e-05 | 196 | 237 | 10 | 1921_DN | |
| Drug | Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; PC3; HG-U133A | 4.17e-05 | 196 | 237 | 10 | 1961_UP | |
| Drug | C070379 | 4.74e-05 | 199 | 237 | 10 | CID003034747 | |
| Drug | NAADP | 5.05e-05 | 39 | 237 | 5 | CID000123952 | |
| Drug | 2brh | 5.96e-05 | 21 | 237 | 4 | CID000848641 | |
| Drug | Dantrolene | 6.47e-05 | 41 | 237 | 5 | ctd:D003620 | |
| Drug | W7 hydrochloride | RYR1 RYR3 S100A11 MYLK3 VIPR1 ODC1 MYLK2 MTTP ATP2A2 ATP2B2 ATP2B4 | 6.67e-05 | 250 | 237 | 11 | CID000005681 |
| Drug | AC1L1IZE | 7.06e-05 | 131 | 237 | 8 | CID000004799 | |
| Drug | indo-1 | 8.00e-05 | 99 | 237 | 7 | CID000105060 | |
| Drug | AC1L9LJU | 9.67e-05 | 137 | 237 | 8 | CID000448056 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 1.08e-04 | 2 | 237 | 2 | ctd:C005147 | |
| Drug | 5-(5-(3-chloro-5-ethoxy-4-hydroxybenzylidene)-3-methyl-4-oxothiazolidin-2-ylideneamino)-2-chlorobenzoic acid | 1.08e-04 | 2 | 237 | 2 | ctd:C558243 | |
| Drug | HF-2035 | 1.22e-04 | 25 | 237 | 4 | CID006439511 | |
| Drug | KB-R7943 | 1.26e-04 | 47 | 237 | 5 | CID004534086 | |
| Drug | PCB 95 | 1.27e-04 | 10 | 237 | 3 | CID000038012 | |
| Drug | 1sqc | 1.27e-04 | 10 | 237 | 3 | CID000444279 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 4.74e-07 | 3 | 231 | 3 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 4.74e-07 | 3 | 231 | 3 | DOID:8545 (implicated_via_orthology) | |
| Disease | alcohol use disorder (implicated_via_orthology) | 3.49e-06 | 195 | 231 | 10 | DOID:1574 (implicated_via_orthology) | |
| Disease | platelet aggregation | 2.67e-05 | 45 | 231 | 5 | GO_0070527 | |
| Disease | urate measurement, bone density | PLB1 ITGB6 FREM1 STRN PTPRD SEC16A CPSF2 FAM135A MPP7 SYNE1 CARMIL1 TIPARP RBM6 CAMKMT ATP2B2 ATP2B4 | 3.36e-05 | 619 | 231 | 16 | EFO_0003923, EFO_0004531 |
| Disease | interferon gamma measurement | 4.93e-05 | 51 | 231 | 5 | EFO_0008165 | |
| Disease | severe acute respiratory syndrome, COVID-19 | EPHB2 USP9X SPEF2 CCDC178 NLN HSPA12A PTPRD DIAPH2 USP12 SIPA1L2 MXRA5 MALRD1 ZFHX3 | 5.72e-05 | 447 | 231 | 13 | EFO_0000694, MONDO_0100096 |
| Disease | Macrocephaly | 7.46e-05 | 11 | 231 | 3 | C0221355 | |
| Disease | diastolic blood pressure, systolic blood pressure | RYR2 EHD4 RTF1 CEP350 SEC16A CHD6 CARMIL1 PPARG DNAH7 PPP4R3B LIG1 MALRD1 GDF7 ZFHX3 ATP2B4 PCM1 | 8.52e-05 | 670 | 231 | 16 | EFO_0006335, EFO_0006336 |
| Disease | dihomo-linoleate 20:2n6 measurement | 1.82e-04 | 3 | 231 | 2 | EFO_0021064 | |
| Disease | Disorder of eye | 2.82e-04 | 212 | 231 | 8 | C0015397 | |
| Disease | Colorectal Carcinoma | CSMD3 NF1 PTPRD MYLK3 SACS DNAH3 CAD SYNE1 ODC1 STAM PPARG POSTN LIG1 MLH3 CHD5 | 4.61e-04 | 702 | 231 | 15 | C0009402 |
| Disease | post-traumatic stress disorder symptom measurement | 4.71e-04 | 82 | 231 | 5 | EFO_0008535 | |
| Disease | Deaf Mutism | 4.89e-04 | 20 | 231 | 3 | C4082305 | |
| Disease | Deafness, Acquired | 4.89e-04 | 20 | 231 | 3 | C0751068 | |
| Disease | Hearing Loss, Extreme | 4.89e-04 | 20 | 231 | 3 | C0086395 | |
| Disease | Complete Hearing Loss | 4.89e-04 | 20 | 231 | 3 | C0581883 | |
| Disease | Bilateral Deafness | 4.89e-04 | 20 | 231 | 3 | C3665473 | |
| Disease | Prelingual Deafness | 4.89e-04 | 20 | 231 | 3 | C0011052 | |
| Disease | juvenile myelomonocytic leukemia (implicated_via_orthology) | 6.01e-04 | 5 | 231 | 2 | DOID:0050458 (implicated_via_orthology) | |
| Disease | age at menopause | 6.67e-04 | 302 | 231 | 9 | EFO_0004704 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 6.85e-04 | 51 | 231 | 4 | cv:CN043650 | |
| Disease | glucose-dependent insulinotropic peptide measurement | 7.93e-04 | 53 | 231 | 4 | EFO_0008464 | |
| Disease | Intellectual Disability | SETD1A NF1 SACS CCDC47 SCN3A IQSEC1 PUF60 SYNE1 CHD8 NBEA ODC1 | 8.57e-04 | 447 | 231 | 11 | C3714756 |
| Disease | Ectodermal Dysplasia | 8.97e-04 | 6 | 231 | 2 | C0013575 | |
| Disease | Hailey-Hailey disease (implicated_via_orthology) | 8.97e-04 | 6 | 231 | 2 | DOID:0050429 (implicated_via_orthology) | |
| Disease | Drugs used in diabetes use measurement | 9.50e-04 | 255 | 231 | 8 | EFO_0009924 | |
| Disease | Deafness | 9.59e-04 | 25 | 231 | 3 | C0011053 | |
| Disease | alcohol use disorder measurement, alcohol consumption measurement | 1.01e-03 | 97 | 231 | 5 | EFO_0007878, EFO_0009458 | |
| Disease | pseudotumor cerebri | 1.08e-03 | 26 | 231 | 3 | EFO_1001132 | |
| Disease | Adenoid Cystic Carcinoma | 1.16e-03 | 100 | 231 | 5 | C0010606 | |
| Disease | gait measurement | 1.21e-03 | 150 | 231 | 6 | EFO_0007680 | |
| Disease | Adenocarcinoma of lung (disorder) | 1.24e-03 | 206 | 231 | 7 | C0152013 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 1.25e-03 | 7 | 231 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | asphyxiating thoracic dystrophy (is_implicated_in) | 1.25e-03 | 7 | 231 | 2 | DOID:0050592 (is_implicated_in) | |
| Disease | Cholangitis | 1.25e-03 | 7 | 231 | 2 | C0008311 | |
| Disease | Retinitis Pigmentosa | 1.38e-03 | 104 | 231 | 5 | C0035334 | |
| Disease | caudate nucleus volume | 1.64e-03 | 30 | 231 | 3 | EFO_0004830 | |
| Disease | progressive supranuclear palsy | 1.81e-03 | 31 | 231 | 3 | MONDO_0019037 | |
| Disease | endometrial carcinoma | 1.99e-03 | 113 | 231 | 5 | EFO_1001512 | |
| Disease | response to diuretic, low density lipoprotein cholesterol measurement | 2.12e-03 | 9 | 231 | 2 | EFO_0004611, GO_0036270 | |
| Disease | vein graft stenosis | 2.12e-03 | 9 | 231 | 2 | EFO_0007051 | |
| Disease | susceptibility to mononucleosis measurement | 2.12e-03 | 69 | 231 | 4 | EFO_0008403 | |
| Disease | Drug habituation | 2.15e-03 | 115 | 231 | 5 | C0013170 | |
| Disease | Drug abuse | 2.15e-03 | 115 | 231 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 2.15e-03 | 115 | 231 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 2.15e-03 | 115 | 231 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 2.15e-03 | 115 | 231 | 5 | C0013222 | |
| Disease | Drug Dependence | 2.15e-03 | 115 | 231 | 5 | C1510472 | |
| Disease | Substance Dependence | 2.15e-03 | 115 | 231 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 2.15e-03 | 115 | 231 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 2.15e-03 | 115 | 231 | 5 | C0029231 | |
| Disease | Substance abuse problem | 2.23e-03 | 116 | 231 | 5 | C0740858 | |
| Disease | C-reactive protein measurement, high density lipoprotein cholesterol measurement | 2.37e-03 | 34 | 231 | 3 | EFO_0004458, EFO_0004612 | |
| Disease | hippocampal volume | 2.48e-03 | 297 | 231 | 8 | EFO_0005035 | |
| Disease | complement C1q subcomponent subunit C measurement | 2.63e-03 | 10 | 231 | 2 | EFO_0801492 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 2.63e-03 | 10 | 231 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 2.63e-03 | 10 | 231 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | response to carboplatin, response to antineoplastic agent | 2.63e-03 | 10 | 231 | 2 | GO_0097327, GO_0097328 | |
| Disease | triacylglycerol 54:1 measurement | 2.63e-03 | 10 | 231 | 2 | EFO_0010419 | |
| Disease | Retinitis pigmentosa | 2.74e-03 | 74 | 231 | 4 | cv:C0035334 | |
| Disease | atrial fibrillation | 2.74e-03 | 371 | 231 | 9 | EFO_0000275 | |
| Disease | sexual dimorphism measurement | RPN2 PABPC4 VPS33A CNBD2 NF1 PMPCA SEC16A MGA ZFAT TENT5A R3HCC1 BAZ1B JMJD1C MADD ZBTB46 MYO1F RBM6 ZFHX3 | 2.87e-03 | 1106 | 231 | 18 | EFO_0021796 |
| Disease | Nonsyndromic genetic hearing loss | 3.02e-03 | 76 | 231 | 4 | cv:C5680182 | |
| Disease | colorectal carcinoma (is_marker_for) | 3.02e-03 | 37 | 231 | 3 | DOID:0080199 (is_marker_for) | |
| Disease | polybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement | 3.20e-03 | 11 | 231 | 2 | EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964 | |
| Disease | Diabetic Cardiomyopathies | 3.20e-03 | 11 | 231 | 2 | C0853897 | |
| Disease | quality of life during menstruation measurement, acne | 3.20e-03 | 11 | 231 | 2 | EFO_0003894, EFO_0009366 | |
| Disease | physical activity measurement | 3.30e-03 | 245 | 231 | 7 | EFO_0008002 | |
| Disease | upper aerodigestive tract neoplasm | 3.38e-03 | 246 | 231 | 7 | EFO_0004284 | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 3.64e-03 | 80 | 231 | 4 | DOID:6432 (biomarker_via_orthology) | |
| Disease | Inherited neuropathies | 3.78e-03 | 40 | 231 | 3 | C0598589 | |
| Disease | Nonsyndromic Deafness | 3.80e-03 | 81 | 231 | 4 | C3711374 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 3.82e-03 | 12 | 231 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | complement component C7 measurement | 3.82e-03 | 12 | 231 | 2 | EFO_0008093 | |
| Disease | congestive heart failure (implicated_via_orthology) | 4.05e-03 | 41 | 231 | 3 | DOID:6000 (implicated_via_orthology) | |
| Disease | smoking cessation | 4.27e-03 | 325 | 231 | 8 | EFO_0004319 | |
| Disease | Giant Cell Glioblastoma | 4.33e-03 | 84 | 231 | 4 | C0334588 | |
| Disease | Zellweger Spectrum | 4.50e-03 | 13 | 231 | 2 | C3658299 | |
| Disease | Zellweger-Like Syndrome | 4.50e-03 | 13 | 231 | 2 | C0751594 | |
| Disease | Vertigo | 4.85e-03 | 139 | 231 | 5 | HP_0002321 | |
| Disease | bipolar I disorder | 5.15e-03 | 141 | 231 | 5 | EFO_0009963 | |
| Disease | polycystic kidney disease (implicated_via_orthology) | 5.22e-03 | 14 | 231 | 2 | DOID:0080322 (implicated_via_orthology) | |
| Disease | monocyte percentage of leukocytes | SPEF2 STK38 EHD4 NF1 PMPCA SEC16A USP12 TENT5A MEI1 JMJD1C MADD MYO1F SSH2 | 5.28e-03 | 731 | 231 | 13 | EFO_0007989 |
| Disease | liver volume | 5.99e-03 | 15 | 231 | 2 | EFO_0600048 | |
| Disease | Adrenoleukodystrophy, Neonatal | 5.99e-03 | 15 | 231 | 2 | C0282525 | |
| Disease | tumor necrosis factor beta measurement | 5.99e-03 | 15 | 231 | 2 | EFO_0008308 | |
| Disease | hemorrhoid | 6.12e-03 | 147 | 231 | 5 | EFO_0009552 | |
| Disease | neutrophil count | MYCBP2 MCM6 EHD4 RTF1 PMPCA IQSEC1 CHST12 TENT5A PCDHA1 XPO1 CREBBP YWHAE JMJD1C MST1R RSBN1 THRA CD58 SSH2 STK38L PCNT | 6.31e-03 | 1382 | 231 | 20 | EFO_0004833 |
| Disease | Colorectal Neoplasms | 6.39e-03 | 277 | 231 | 7 | C0009404 | |
| Disease | decreased susceptibility to hepatitis C infection | 6.81e-03 | 16 | 231 | 2 | EFO_0010101 | |
| Disease | shigellosis | 6.81e-03 | 16 | 231 | 2 | EFO_0005585 | |
| Disease | Zellweger Syndrome | 6.81e-03 | 16 | 231 | 2 | C0043459 | |
| Disease | T-Cell Lymphoma | 6.81e-03 | 16 | 231 | 2 | C0079772 | |
| Disease | gliosarcoma | 6.81e-03 | 16 | 231 | 2 | C0206726 | |
| Disease | C-reactive protein measurement | PABPC4 FAM114A2 NCL CCDC168 PTPN3 STRN HSPA12A SEC16A PCDH15 MERTK CAD CARMIL1 BAZ1B CEP192 MADD MST1R ZBTB46 ARMH4 | 6.94e-03 | 1206 | 231 | 18 | EFO_0004458 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.03e-03 | 152 | 231 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | hearing impairment | 7.45e-03 | 98 | 231 | 4 | C1384666 | |
| Disease | fatty liver disease (is_marker_for) | 7.68e-03 | 17 | 231 | 2 | DOID:9452 (is_marker_for) | |
| Disease | Moyamoya Disease | 7.68e-03 | 17 | 231 | 2 | C0026654 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EFDFTEDTGNIEARK | 321 | O75410 | |
| VEDFLALTGIESADK | 551 | Q15361 | |
| KAAFDDAIAELDTLS | 196 | P62258 | |
| TFDIASDAFATFKDL | 176 | Q9H9S4 | |
| FVLKADDDSFARLDA | 151 | Q96L58 | |
| SFLVEFEDSTDKSVI | 101 | Q9Y2D0 | |
| RHFSTLKDDDLVEFS | 1406 | Q9HCK8 | |
| FQLEFEEALATSASK | 46 | Q5JVX7 | |
| LDFITDAENTSKGFE | 1186 | Q7Z408 | |
| FDLESQFDFLAVKDG | 766 | Q7Z407 | |
| YEVESSLEDASFEKA | 106 | Q8IX94 | |
| YEVESSLEDASFEKA | 106 | Q86UF2 | |
| YEVESSLEDASFEKA | 106 | P0CG41 | |
| YEVESSLEDASFEKA | 106 | A4FU28 | |
| YEVESSLEDASFEKA | 106 | A4D2H0 | |
| TDGDKAFVDFLSDEI | 76 | Q07021 | |
| LEGFLEEFADISKED | 901 | Q8TDI0 | |
| LFESDLESGKFIDIT | 2576 | Q68DQ2 | |
| FTLFTLDDVDAAFDK | 111 | Q9P2I0 | |
| DEFLEKLETSEFFEL | 726 | Q9UIG0 | |
| FTESTKENDALFFLE | 421 | Q86TY3 | |
| DSTDFGSLFDLENDL | 26 | Q92793 | |
| SSKFDDLIFDEEEGA | 161 | Q8WYK0 | |
| DGDLIATKEEFTAFL | 166 | O43852 | |
| SFNVDFDDTENKSVL | 66 | Q8N1Q1 | |
| LRFFSEKSAGTVELD | 511 | P07384 | |
| FDSKTVSIEEFFGDL | 981 | O60879 | |
| TFLEDDTDETFTKGE | 41 | Q96MT7 | |
| KEASDIILTDDNFSS | 846 | Q01814 | |
| KEASDIILTDDNFTS | 811 | P23634 | |
| QFGDEKTFSDSSLLE | 451 | Q9Y2Q0 | |
| TEDLLATFSEFQEKG | 331 | Q9Y3T6 | |
| FSKSELASAVLEAVE | 351 | Q96QF0 | |
| LAFKDNEEFESSFES | 816 | O75665 | |
| SFADFKSEDELNQLF | 601 | P26045 | |
| FQDKSEEASLDLVFE | 211 | Q7Z3E1 | |
| KDIFSEFSSAGLTDI | 191 | Q7Z5J8 | |
| SSETELTLFGFKDLE | 201 | A5PLL1 | |
| DDEIDSYFKESINLS | 281 | Q8N635 | |
| EAEVLFSFSLEESLK | 951 | Q6ZW49 | |
| DSDIFTFSVSLEIKE | 286 | Q9Y3P9 | |
| DTKSIRAFAEGFLAE | 101 | Q96NR8 | |
| SELEDFELDKSADFS | 716 | Q9NVI1 | |
| EVDDESLKELFSQFG | 201 | Q13310 | |
| LDFLEEFQSSDGEIK | 31 | Q14566 | |
| AADDFRTKFETEQAL | 161 | P08727 | |
| TAFVAEDKFITLAAE | 741 | Q14667 | |
| DKVAELENSEFRAFS | 61 | P19256 | |
| LRDDTSFVFTLTDKD | 71 | Q8WXG6 | |
| QFDDDDLSVITGAFK | 1006 | Q9NPP4 | |
| FSSVTEEELNFEKGE | 206 | O43639 | |
| DGVLFVSFESKEALD | 661 | Q8IWI9 | |
| HTRSFTFKVEEEDDA | 46 | O75607 | |
| ETKFGNAFTEEDSEL | 531 | Q12866 | |
| SDDKIEDELQTFFTS | 6 | Q9ULD2 | |
| EDELQTFFTSDKDGN | 11 | Q9ULD2 | |
| DSVPVISFKDAAFDD | 666 | Q96S38 | |
| KLFLSDGNTSEFTDI | 591 | Q9P2D0 | |
| TREEELKSLGADFTF | 161 | Q96T76 | |
| DLKFVFDAVFDETST | 71 | Q8NI77 | |
| GLSNAAFESDFKEIE | 591 | Q8NI77 | |
| DFADAITELEDAFSR | 231 | Q6DN90 | |
| LVDKQLDFLTEDSAF | 131 | Q15652 | |
| DALTEFGIFSEEDKD | 141 | Q9BVA6 | |
| TDLFEKGNADEFTIE | 596 | Q8IVV2 | |
| ELSDVAKDFSAISLA | 431 | Q5BJE1 | |
| LLVFGSVSEAKFDDF | 11 | Q96A33 | |
| KVSDFGLSRFLEDDT | 761 | P29323 | |
| LQFVFSDEETSSDVK | 921 | Q9P2D6 | |
| ATTDDETFEKNFERE | 1466 | Q15154 | |
| IKSGEEDFESLASQF | 96 | Q13526 | |
| LAGATISEEEDFSKD | 651 | P18564 | |
| DIKEFSEDNGFSLFD | 361 | Q9UHC1 | |
| SLEAILDFLDFKSDS | 371 | P55157 | |
| FEGLSEEAKDFVSRL | 736 | Q32MK0 | |
| FEAVSDEAKDFVSNL | 506 | Q9H1R3 | |
| DDSDSTKDFVVFRIF | 486 | Q5H8C1 | |
| DDLTVAFNELKTTFD | 546 | Q5T2T1 | |
| DFERFSKVLEEAAAA | 321 | O43293 | |
| ELTAAAKEGELSVFF | 301 | Q8N5J2 | |
| RKSPVFSDEDSDLDF | 161 | O00566 | |
| FSDEDSDLDFDISKL | 166 | O00566 | |
| EIFFTAEKTDELGLA | 651 | P50748 | |
| IDLSSVQKASFEELF | 286 | A0A087WXM9 | |
| LFDAHKLDISDEFSE | 191 | Q9H223 | |
| LSKFTGQAVELFDEE | 271 | Q86UY5 | |
| SAAELQDLLDVSFEF | 886 | Q9UGL1 | |
| DVFDKFISADQSVAL | 566 | O43301 | |
| KFLSEVFAQLTDEAT | 311 | Q5MIZ7 | |
| LEDSIDNKALYDTFS | 106 | Q4VXU2 | |
| TEEFFSTLDSNLEKA | 16 | Q6ZWE6 | |
| GSKDSFAVLLEFAEE | 151 | P54368 | |
| FSFKNVISLTEDVDE | 201 | P16144 | |
| AVEKDVEDFITTSFD | 2306 | O95613 | |
| LLADEKFDFDLSLSS | 11 | Q9NYZ3 | |
| DSSSIFEEETFGIKR | 331 | Q8IVE3 | |
| AFIEFASFEDAKEAL | 526 | P19338 | |
| KEDTLEAFSEFLLSA | 536 | Q5TIA1 | |
| FDEEVGSDSAELFRK | 996 | O95248 | |
| DYFSLDVEASDELSK | 176 | Q9Y5I3 | |
| EDFDSEKEISQIFST | 56 | Q8WX93 | |
| LEKSEDSLSDQEGSF | 341 | Q4G163 | |
| EELSLFGDEDFQLKF | 1426 | Q5VYJ5 | |
| FDFSEKLNSLALTEE | 521 | P20393 | |
| RKFTFLSDEDDLSAH | 1511 | Q96QU1 | |
| SQEKFFQELFDSELA | 66 | P40855 | |
| SFSFSDVEDLLAEAK | 936 | Q9Y4D1 | |
| DVTSKAFTGREFDEL | 646 | P16615 | |
| VGSFEEDSKSEFILD | 2316 | Q9ULT8 | |
| VCKTLENFFASADEE | 556 | Q8NFZ0 | |
| DSVELFIFDSAGKEL | 56 | Q9BW83 | |
| LELFDLDETFSSEKA | 351 | Q9Y366 | |
| TVFFSEKEHLDLETS | 131 | Q9BX69 | |
| FIVDSSESSKIALFD | 51 | Q2UY09 | |
| FSSEELKNSGLTEEE | 381 | P13671 | |
| SINAFEDDILTKIFS | 2211 | Q8TD57 | |
| DLEAARESFASEFQK | 286 | Q8TDB6 | |
| KDAFDFESRSEIANL | 36 | Q96MS3 | |
| ELAKLSADVTFATEF | 106 | Q96JJ3 | |
| SETAFLEEFGDLKTE | 651 | Q8TD26 | |
| FDEEFFSQTSELAKD | 246 | Q9UIK4 | |
| KGAADTTIILSDEDF | 681 | P51659 | |
| FSKALQEDDDLDFSL | 31 | O00409 | |
| QFLKIDTIAADESFT | 141 | P29322 | |
| FLFTDTQIKEESFLE | 2396 | Q8WXX0 | |
| KVSIAAEDDTLDNTF | 2676 | Q5VT06 | |
| ISNADSFEEEAIIKS | 136 | Q5T1N1 | |
| FLLDTSSSVGKEDFE | 41 | Q8NFW1 | |
| DEDFTKDITELFSQL | 306 | Q9NRY5 | |
| SSDILDSAEEFSAKV | 1606 | Q8TEP8 | |
| ESLTFKDVFVDFTLE | 6 | Q5JUW0 | |
| KSNDSGEEAEKEFIF | 1356 | Q5VZK9 | |
| AEFEEFAGLAESIFK | 676 | Q9NV70 | |
| ISKTDEAFFDSENDP | 1971 | Q9H583 | |
| EQLFFTESSKDGSLE | 321 | Q6PJP8 | |
| SEDVLLGETFFSKSQ | 2546 | Q8NDH2 | |
| DEDFDSKLSFREFLL | 141 | Q96C19 | |
| DSLEGEDFEKEFSFL | 336 | Q8NDH6 | |
| EDFSETLTRAKFEEL | 316 | P11021 | |
| ADFSAAELISVSKFL | 1121 | Q86VB7 | |
| GEFVFATSLDTKDIE | 691 | P18858 | |
| DSKEISELSDQFAPF | 236 | Q9NZJ4 | |
| QFEDVKFEAASLLSE | 101 | Q9Y6X3 | |
| GLRSFFESASEDIEK | 3091 | P21817 | |
| ILLDDSGSELAFKDF | 1181 | Q92736 | |
| SEEFNATKLFEVDTD | 281 | B1AKI9 | |
| VSSSDDKDAFYVADL | 31 | P11926 | |
| LTDEDFDQFVKEHSS | 281 | Q14554 | |
| LEDDDFFTGEKSSDI | 1746 | Q9HC10 | |
| LEFSEKEDHFTATDI | 871 | P23468 | |
| LAAISDFVGKDEEFT | 361 | O14926 | |
| IDDSSEEFVNFAAIL | 51 | Q59EK9 | |
| ASDLSEDLFKVHDFD | 651 | Q92541 | |
| FSEEFLALTFSENEK | 391 | Q5VWQ0 | |
| IKAFEDLETDDFTTA | 741 | Q15542 | |
| AFSSTARFDSKDEIL | 116 | Q10713 | |
| ALEFFNSLVDSLDEA | 1686 | Q93008 | |
| EFTDAKHESLFSLET | 156 | Q68CQ4 | |
| SDLDFRDKDGTQVDF | 221 | P78332 | |
| DFSEFLDSRVSSAKL | 46 | Q9C093 | |
| ALKEFDFLVTAEDGE | 301 | Q13033 | |
| IKSIDDTSNFDEFPE | 401 | Q15208 | |
| DTSNFDEFPESDILK | 406 | Q15208 | |
| DSASVLDNFKFLESA | 226 | O43815 | |
| DLDSDTADKFLQLFG | 431 | Q96LD4 | |
| FTHDSFEKAELSVLE | 146 | Q32P41 | |
| NETFSFKADATELDT | 346 | Q9BQS2 | |
| EIKSIDDTSNFDDFP | 401 | Q9Y2H1 | |
| DLSDDDIKSVFEAFG | 236 | Q9UHX1 | |
| AFLEFSKEVDAQSSL | 6841 | Q8NF91 | |
| SFLESIDDALAEKAS | 116 | Q15750 | |
| AEDSEREKFSLFSAA | 171 | Q96ER9 | |
| AKEVATEEFNSDISL | 1961 | Q5UIP0 | |
| SNTDGIDSFLDKVDE | 186 | O14975 | |
| SNSFELDLQFSEDEK | 421 | O15530 | |
| SFSLADFDRKASAEI | 1951 | Q9NTG1 | |
| VFASSLNFSEIEAEK | 1446 | Q8NFP9 | |
| FLFDVSSLNDADEVV | 141 | Q7Z4P5 | |
| FEFAVKFNALELDDS | 396 | P37231 | |
| FIEFSKLSDFAAALD | 1796 | Q15858 | |
| EHETFKFTSELEESR | 301 | Q9P2F8 | |
| EALFSLETASDYVKD | 2116 | O75592 | |
| DATAETDLAKRFDVS | 236 | P13667 | |
| IDDFESKFTFHSVED | 416 | A6NGB9 | |
| KLDTNSDGQLDFSEF | 66 | P31949 | |
| DPDATQFIEFSKLSD | 1801 | Q9NY46 | |
| LFSADEDEITIGAEK | 151 | Q96LD1 | |
| FILDQSASFKDEVLA | 471 | Q2KHM9 | |
| KFDDNSTELATLIEF | 586 | Q6P1J6 | |
| SKFSFLASDTEEEEE | 501 | O15047 | |
| VLKDEFSSFSELSSA | 16 | Q8N5C6 | |
| LFEDAFDVASFLDKS | 246 | Q7Z7C7 | |
| TFKEFLLSLDDSVDE | 151 | Q9BXP5 | |
| FFQTKALDVSASDDE | 176 | P13798 | |
| SDKYAALAELDSVFS | 371 | P52594 | |
| ESFNLFSVTEGKERE | 66 | Q7Z624 | |
| DTDDLILENFYDKTS | 161 | O14967 | |
| VAITKDEDGSSAFLD | 161 | Q96M20 | |
| TADSDVDEFLDKFLS | 61 | Q9NRB3 | |
| GDKLSDESIFSAFLS | 1251 | Q15021 | |
| LNEDDTFLVFSKAEL | 206 | Q9BYT8 | |
| SDLEALFQDFKDCDF | 621 | A0JNW5 | |
| QIKEFAGEDTSDLFL | 1021 | O14980 | |
| AVFIKDLALFDSGES | 191 | P32241 | |
| EVVSDDFLLKNDTSS | 591 | Q9P243 | |
| LLSKEFIDFSDTDEV | 921 | Q9C0E2 | |
| EFDVSFRSAEKLALF | 211 | Q9NUD5 | |
| NSLSELSEENFDGKF | 2036 | O15027 | |
| DFFSALEKFVELSQE | 651 | Q76I76 | |
| FELDTSERKIEFDSA | 461 | P04844 | |
| FFENAAEDLEKTSEN | 2956 | Q15413 | |
| FSLYEDEISDSKAQL | 611 | Q96QK1 | |
| SFAFLTAEDSAQKTE | 591 | Q5T4T6 | |
| KAAELDSTEFDVVFN | 736 | Q8N394 | |
| SNFIKDAVLFSSDDV | 191 | P47872 | |
| TISSKDEDFLDLSVD | 191 | O75317 | |
| SVEGSKEFTFSLLDA | 341 | Q8IY51 | |
| AEKLFDLVDGFAEST | 246 | P21359 | |
| STSNILASEFFEEEK | 1161 | Q92576 | |
| FEAAEDNELTFKAGE | 221 | Q92783 | |
| IDSSDKVDFFILLDN | 241 | Q9NPH0 | |
| FFNSLVDSLDEALKA | 1691 | O00507 | |
| KFNSSFEIHDDTEVL | 281 | Q5H9I0 | |
| DLERFLSSAAAVSKE | 1106 | P27708 | |
| LETFDSLTDLVEHFK | 181 | P29350 | |
| ESFSFDDLSVDFTQK | 6 | P51523 | |
| DDFFTEDTSGLLELK | 146 | Q9HBG4 | |
| DSIFHSVRAEDDFKE | 146 | Q9NS56 | |
| DGDKVDLEAFSEFTK | 206 | P10827 | |
| DDDELIFVGEISSSK | 41 | Q8ND82 | |
| TSEDFFDKLTVEQEF | 366 | Q96AX1 | |
| KDSSFEDLEQFLGTS | 376 | Q9Y2B5 | |
| ESLTFKDVFVDFTLE | 6 | Q2M3X9 | |
| DKRFSTFLSLLEAAD | 506 | Q15063 | |
| SEIIDFFLGASLKDE | 91 | P15880 | |
| FEDVSYESTLKALAD | 56 | P52888 | |
| FEFSVDSFQIKLDSL | 226 | Q96IP4 | |
| AEVTSETFNKEAFLA | 381 | Q9H091 | |
| LDESFTVKVADFGLA | 1216 | Q04912 | |
| GNIDLESDSFLKFDS | 146 | P18583 | |
| ESDSFLKFDSEPSAV | 151 | P18583 | |
| ISIKSDASDELAEFE | 131 | Q86UZ6 | |
| AEAEELATFNSKTEA | 2411 | Q15911 | |
| SEFDSDQDTIFSREK | 1031 | Q5VV43 | |
| EDAADSFLESVFKTE | 836 | O00160 | |
| KELEDVDFTSEFLSS | 1411 | Q9NR99 |